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Thesis Abstract
Human impact on the environment can be seen in the wide variety of chemicals that are
found in our water and soil. Common contaminants arise from insufficient treatment in
wastewater treatment plants (WWTPs), and runoff from agriculture. Surface water
samples collected in 2017-2020 at 40 different sites in six different watersheds were
analyzed to determine if the commonly targeted emerging substances of concern (ESOCs)
are present in Ontario and Quebec waterways. The diabetes medication metformin was
analyzed more closely alongside its degradation product guanylurea as they have become
targets of increasing interest due to their common occurrences and new toxicological data
on organisms. Sediment samples at the same sampling sites were also collected. This
work is to our knowledge the first long term analysis of metformin and guanylurea in
Ontario and Quebec and offers potentially valuable insight into where metformin and
guanylurea partition and accumulate in waterways.
Biosolid samples from Ontario WWTPs were also analyzed for the presence of ESOCs to
determine if treatment used to remove micropollutants and bacteria is also able to remove
common chemical contaminants. Two extraction methods were assessed to determine
their efficacy in extracting a wide variety of compounds. The concentrations of extracted
compounds were also compared between the untreated biosolid cake and treated fertilizer
to determine if a thermal hydrolysis process (THP) could degrade ESOCs. This work
serves to validate a widespread biosolid analysis method for use in further
ecotoxicological studies.
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Summary for Lay Audience
We use a wide variety of chemicals in everyday life, whether for medicine, agriculture, or
recreational use. Once we have used these chemicals, very few of them degrade and get
removed from the ecosystem. In fact, many of them can be found in surface water and
soil around the world. Some of these compounds are relatively harmless, while others can
be toxic to plants and animals. Even more worryingly, there are many compounds that we
have not detected yet, or whose effects we do not know. This makes it a priority in
environmental contamination studies to have ways to identify these compounds, and to
figure out how much is there. In this work, we use methods to detect these compounds
and determine how much is present at various sites in Canada. By doing this, we can
ensure that chemicals that are present in high amounts can be regulated to manage their
risk. Also, because our samples come from between 2017-2020, we can determine if the
amount of chemicals have been increasing in the environment and figure out which
compounds are most important to restrict.
To investigate environmental contamination, we examine water, sediment, and biosolids.
The water and sediment samples come from rivers, lakes, and streams around Canada,
and each site we look at has different things nearby. For example, a sample taken from a
river going through a city should contain different compounds than a sample from a river
going through farmland. We can identify those compounds in water and sediment to
make sure there is nothing toxic or dangerous present. Biosolids are the solid waste
produced by humans after it has been treated in a wastewater treatment plant. This waste
can be cleaned up and used as fertilizer, but we need to make sure that any harmful
chemicals that may have been in the human waste have been removed, otherwise it may
impact the farmland it is applied to. These types of samples are all important to
investigate to make sure that we are not damaging our environment in any way.
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Chapter 1
Introduction

2

1.1 Environmental Contamination
Human impact on the environment can be observed by the widespread occurrence of
human-created chemicals in water,1–3 soil,4–6 and plants.7–9 Compounds are continuously
synthesized to treat new illnesses, control pests, and improve chemical processes. As
these new compounds are created, they often find their way into our surface water, and
can cause untold harm to both the aquatic environment and the organisms that live
there.10,11 It is of great importance to identify and quantify the compounds that
contaminate our watersheds to ensure that they are not present in amounts that cause
harmful effects. To investigate this environmental contamination, regions can be divided
into watersheds, i.e., land areas in which all surrounding water sources drain into a
common body of water. Watersheds can vary in size based on the drainage and
topography of the area but are a point of accumulation for all water in a large area, and
therefore allow for insight into all contamination that is occurring in surface water in a
region.
Emerging substances of concern (ESOCs) are common environmental contaminants that
have been identified as having possible health risks12. Some ESOCs have unknown
effects and are common in the environment, while others are found rarely but have severe
and known toxic effects. Investigations into ESOCs can therefore vary, as some studies
seek to create a method to detect the compounds, some seek to quantify them, and others
seek to characterize their toxic effects and at what concentrations they occur. Several
regulatory bodies in Canada, including the Pest Management Regulatory Agency
(PMRA), Health Canada (HC) and Environment and Climate Change Canada (ECCC),
place regulations on ESOCs in a multitude of categories. PMRA is responsible for
regulation of pest control products such as herbicides and insecticides, HC manages
pharmaceuticals in the environment, while ECCC places regulations on a variety of fields
to limit newly identified contaminants and their spread. When regulatory agencies such as
these identify a potentially hazardous compound, that contaminant becomes a target for
environmental studies to determine how common it is, and if it is hazardous to the
environments in which it is found. Once environmental concentrations have been
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recorded, toxicology studies can identify if the levels detected are high enough to exhibit
toxic effects in aquatic organisms. New regulations can then be put in place if
environmental concentrations approach the levels at which adverse effects occur. New
compounds are created and identified every year, so this is an ever-repeating pipeline of
events to prevent any major deleterious effects as a result of human contamination.

1.1.1 Contamination of Pharmaceuticals
Pharmaceuticals and personal care products (PPCPs) are one class of compounds that
includes medications, illicit drugs, and cosmetics. New pharmaceuticals are developed
every year to treat both physical and mental illnesses and have a variety of structures and
effects. PPCPs can be subdivided into groups based on effects and structures of the
compound.13 Of the many groups of PPCPs, non-steroidal anti-inflammatory drugs
(NSAIDs), macrolides, antidepressants, and antipsychotics are some of the commonly
observed groups in environmental systems.14 The compound structure varies based on the
target area and the desired effect in the body (Figure 1). Many of these complex
pharmaceuticals consumed by humans are metabolically unchanged by the body, and are
therefore excreted in their original forms.15 This human waste ends up in wastewater
treatment plants (WWTPs) where many of the compounds cannot be effectively
degraded, and are then released into the environment in the treated wastewater effluent.16–
19

Because many of these compounds are designed to have some biological effect on the

humans that consume them, there may be undiscovered effects on aquatic organisms in
the environments near the effluent pipes. As prescriptions and usage of the drugs increase
with

higher

surrounding

populations,

there

should

be

higher

environmental

concentrations found in nearby watersheds.20 Previous studies have noted a correlation of
surface water concentrations of environmental contaminants increasing with population.21
The highest concentration of these PPCPs in the watershed should be in or near a
wastewater effluent pipe, and the compound should dilute as distance from the WWTP
increases.21
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a)

b)

c)

d)

Figure 1: Example of types of pharmaceuticals. a) NSAID antipyrine, b) macrolide
clarithromycin, c) antipsychotic quetiapine and d) antidepressant sertraline

1.1.2 Contamination of Pesticides
The next class of ESOCs found commonly in the environment are pesticides, which
encompasses herbicides, fungicides, and insecticides.22–24 Each of these types of
pesticides can be further subdivided into classes such as triazines, neonicotinoids,
carbamates, organophosphates, etc. based on their molecular structure or mode of action
(Figure 2). The wide variety of compounds means that methods of detection and
quantification will vary, and the optimal method for one pesticide may not be optimal for
another. The widespread contamination of pesticides poses a severe health and
environmental issue, as many of these compounds are biologically detrimental to humans
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and animals. One study on the children of farmworkers found that prenatal exposure to
organophosphate pesticides led to adverse effects on mental development in children.25
Organophosphates and carbamates both inhibit acetylcholinesterase, which interferes with
degradation of acetylcholine in the brain and can cause severe neurological effects.26,27
Neonicotinoid insecticides are also important to investigate, as their use in recent years
has drastically increased. This increase is due to increasing regulations on other
pesticides, leaving neonicotinoids as the only financially viable option. Neonicotinoid
insecticides were first thought to be less toxic than others, but ongoing toxicological
studies have determined there exist a plethora of toxic effects on vertebrates and
invertebrates, and both acute and chronic exposure to neonicotinoids can cause extremely
toxic or even fatal effects.28 As there has been increasing interest into effects of these
pesticides, it is important to discern how prevalent they are in surface water to determine
the severity of the contamination.

6

Figure 2: Examples of classes of pesticides. a) Triazine herbicide atrazine b)
neonicotinoid insecticide acetamiprid c) carbamate insecticide bendiocarb and d)
organophosphate insecticide malathion

Though many pesticides have toxic effects, their usage in agriculture reduces the impact
of pests on growth of crops, making their use a practical necessity to maximize overall
yield.29 The proliferation of these compounds in the environment can occur in a variety of
ways. Wind during aerosol application of the pesticides can cause the spray to spread
beyond the target, contaminating surrounding areas.30 Additionally, heavy rainfall can
cause the pesticides to leach into the groundwater and diffuse about the watershed in the
surface water.24,31 Different sampling sites in the same region may contain different
compounds due to the variability in human activity and inputs. For more agriculturally
influenced areas, it is expected that the concentration of pesticides would therefore be
higher than in a more urban area.32 Urban areas are not immune to pesticide
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contamination however, as residential use on lawns and in gardens may also lead to
groundwater contamination after heavy rainfall.33

1.2 Environmental Matrices
The compounds identified in environmental samples depend on the matrix that is being
investigated. Certain compounds remain soluble in surface water, some may be retained
by the sediment, while others may be taken up by organisms in the region.34 This means
that different matrices sampled from the same location may give different results, both in
compounds identified and in their concentrations. Due to the different characteristics of
environmental contaminants, it is important to investigate multiple matrices in an area to
discern the extent of the contamination. Each matrix and target compound requires a
separate optimized method to ensure accurate identification and quantification of the
contaminants. The matrices to be investigated in this work are surface water, sediment,
and biosolids.

1.2.1 Surface water
Environmental contaminants often end up in surface water.18,35–37 Rivers, lakes, and
streams amass a wide variety of contaminants from the surrounding areas, and even the
most isolated of places are known to contain small amounts of pharmaceuticals or
pesticides that propagate from populated areas.1 For the purposes of this research, six
watersheds from Ontario and Quebec were examined based on existing sampling
infrastructure and differences in human activity (Figure 3). Conservation authorities at
each watershed took one sample from each site every month from May to October or
November. Monthly sampling allows for a comprehensive assessment of the
contamination at each site, and insight into how contamination changes throughout the
agriculture season. Freezing water samples allows for retrospective analysis of the
samples for any target analyte that is desired. For the purposes of this study, frozen
samples from 2017, 2018 and 2019 were investigated alongside 2020 samples to study
the long-term trends at each site. The methods used to examine these water samples can
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be adjusted to change the target compounds, and in this work, several different targets are
examined using different methods of extraction and analysis.

Figure 3: Six Target watersheds around Ontario and Quebec for 2020. Each sample
site remained constant through the year, and most were sampled through all years
of sampling (2018-2020). Grab samples are small water samples taken to represent
one specific time point at a location.

The first investigation in this work on surface water was to research prevalence of the
pharmaceutical metformin and its degradation product guanylurea in surface water.
Identification and quantification of the compounds in Ontario and Quebec waterways will
be elaborated on in Chapter 2. Each of the watersheds exhibit distinct characteristics due
to their surrounding populations and the degree of agricultural activity occurring nearby,
so this examination is to identify the primary sources of the compounds in the

9
environment, and how much is present at each site. Because metformin is a
pharmaceutical, its usage and occurrence are similar to other PPCPs, and it should
therefore be most prevalent near populated areas and WWTPs.21 Consequently, because
guanylurea is the degradation product of metformin, guanylurea should be in higher
concentrations at sites where more metformin is found, and it should also be present in
the same watersheds.
The second investigation on surface water was to retrospectively analyze the general
trends of concentration for a large target list of ESOCs in water samples taken from 20172020. This will use a large target database to detect as many compounds as possible from
the list to understand the extent of contamination of many ESOCs at the sampling sites.
The samples taken vary both temporally and geographically, so trends can be identified
based on the region, influence at the site, or time. The data resulting from this study can
be saved and retrospectively analyzed based on which compounds are becoming of
interest in environmental studies.

1.2.3 Sediment
Surface water data alone may not give the total representation of environmental
contamination in a region. Sediment underlying water sampling sites in rivers, lakes, and
streams is necessary to investigate as different compounds may have varying mobility
through the matrices.34 Some compounds that end up in surface water may preferentially
bind to sediment, meaning they can accumulate rather than remaining soluble in surface
water, while others may not be absorbed or adsorbed at all.38,39 Depending on the
conditions of the water, some compounds bound to sediment may resolubilize, causing
contamination.40 Sampling of sediment in this work occurs at the same timepoints and
locations as surface water, providing the best possible insight into overall contamination
at each site.
In this work, sediment samples were examined to support the occurrence of metformin
and guanylurea. The extraction method was adapted from a method optimized
specifically for metformin quantification in soil, which was modified to include
guanylurea.41 Because metformin and guanylurea may exhibit different mobility in soil
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and surface water,6 it is important to investigate both matrices to ensure that the
compounds have been identified everywhere they appear. In general, sediment analysis
allows for a deeper understanding of an analyte’s mobility through matrices and is an
invaluable tool in characterization of environmental contaminants.

1.2.4 Biosolids
Biosolids are the solid waste remaining once WWTP treatment has been completed, and
the liquid fraction has been released back into the environment in WWTP effluent. As
biosolids are primarily human waste, they contain many of the same compounds present
in wastewater effluent.42 These biosolids cannot be released back into the environment in
the same manner as wastewater due to micropollutants and bacteria present in the sludge.
Millions of tons of biosolid waste are produced every year, so it is of interest in
conservation efforts to find some use for these solids.43 Several companies have
developed techniques in removing contaminants from biosolids such that they can be
recycled into fertilizer.44 Because these techniques have been developed primarily to
remove bacteria, it is unknown if ESOCs are present, or if the application of these
fertilizers is a point source for their introduction to the environment. There is evidence to
suggest that uptake of some complex pharmaceuticals into crops is possible,7,9 so it is
important to discern if there are ESOCs present in the treated biosolid fertilizer, and if
they are present in hazardous concentrations.
The goal of this study is to determine if the same process that removes bacteria and
micropollutants is also able to remove or reduce concentrations of ESOCs in the treated
fertilizer. Instead of only quantification of the contaminants in the treated fertilizer, what
is being investigated in this case is the difference in concentration before and after
treatment. Treatment of the untreated biosolids (colloquially known as “cake”) utilizes a
thermal hydrolysis process (THP), which exposes the cake to high heat and base while
shearing the solids against a high speed blade to grind the solid material, removing
bacteria and micropollutants. The cake and the treated fertilizer can be subjected to the
same extraction method to quantify the target ESOCs in each. Previous work done by this
lab targeted 5 specific PPCPs in biosolids and demonstrated that the treatment was able to

11
remove 100% of the targeted compounds in water, and around 40% when spiked into
biosolids.45 This may not, however, provide the full picture, as spiked compounds may
not be able to completely absorb into the organic material, and there may be some degree
of protection from degradation by the complex organic matter in the untreated cake. This
can be seen by the drastic decrease in degradation efficiency from water to spiked cake in
the same study.45 This work seeks to further investigate this effect in biosolids using a
general method for ESOC extraction, and to determine conclusively if targeted ESOCs
are removed in the treated fertilizer. Extraction of compounds in biosolids and their
identification will be elaborated on further in Chapter 3.

1.3 Extraction
Extractions from environmental matrices are used to transfer a compound from its
original matrix to another utilizing a molecule’s varying affinity for different
environments. One method of extraction used in this work is accomplished through
thorough mixing of the sample with a second solvent in which it is preferentially soluble.
When the phases intermix, and the analyte comes into contact with the second phase, it
solubilizes into the new solvent, where it remains. The initial solution is then removed to
prepare the targets for analysis. Often the solvents used in extraction are not suitable for
analysis via mass spectrometry as they may be too viscous, may not be miscible with the
mobile phase, or may corrode the tubing or column, among many other possible issues.
To limit these effects, a drying step is used to evaporate the solution and leave the dried
target analytes to be reconstituted in a suitable solvent, usually methanol (MeOH),
acetonitrile (ACN), or water. For environmental samples, specialized methods are
developed based on the matrix and the targets to effectively isolate them from the
complex mixture so they can be analyzed.
Water is a simple matrix for extraction, as it usually requires few steps to clean the
solution, and filtration of the sample is often adequate to remove major biological
contaminants such as algae or silt. Many of the target analytes can be extracted with a
simple extraction method, and concentration of samples from low concentrations is
possible for trace analysis. Sediment and biosolids are more complex matrices that
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require extensive methods to extract the desired compounds and may require multiple
different methods applied to a single sample to accurately quantify all contaminants.

1.3.1 Solid Phase extraction
One valuable method for extraction of environmental contaminants from surface water is
solid phase extraction (SPE).46 This work uses SPE with Oasis Hydrophilic-Lipophilic
Balance (HLB) cartridges to extract a wide variety of ESOCs from surface water. By
slowly passing the surface water under vacuum through the HLB cartridge, the
compounds of interest are loosely bound to the sorbent through electrostatic interactions.
These HLB cartridges contain a copolymer of one hydrophilic monomer (Nvinylpyrrolidone) and one lipophilic monomer (divinylbenzene) (Figure 4).47 These
monomers allow for adequate retention of both polar and nonpolar target analytes, as well
as retention of impurities which can be removed by a washing step prior to elution.

a)

b)

Figure 4: a) Hydrophilic monomer N-vinylpyrrolidone and b) Lipophilic monomer
divinylbenzene used in the copolymer of HLB cartridges. The second vinyl group on
monomer b) can be meta or para substituted.

Compounds of interest can be chemically changed by altering the pH such that they are
uncharged and nonpolar. The weak interactions between the nonpolar analytes and the
cartridge allow the analytes to preferentially adsorb to the cartridge and they can therefore
be removed from the water sample. These weak electrostatic interactions retain the target
compounds which can easily be eluted with a small amount of polar solvent, such as
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MeOH or ACN. This method concentrates the compounds from a larger volume of
sample onto a much smaller cartridge, allowing us to increase the concentration of
compounds that are present in original concentrations of ng/L or lower. As many
sampling sites are located far from WWTP influences, compounds resulting from WWTP
effluent should be quite dilute, so this concentration step is necessary for detection.
Additionally, pesticides in surface water stemming from agriculture are also generally
found in low amounts, which may still be environmentally relevant. Chronic exposure to
some compounds at low levels can still exhibit adverse effects,48 so trace analysis is
necessary to detect and quantify them in these trace amounts. SPE is effective in
amplification of signals for trace analysis of a wide variety of compounds, however each
extraction can be lengthy, which limits the utility of the method.49

1.4 Liquid Chromatography
Although different methods are used depending on the target compounds, one constant in
the environmental analytical chemistry performed here is liquid chromatography (LC).
Chromatography is the separation of a mixture into its components, which is especially
useful when isolating target compounds in a complex mixture, as in an environmental
sample. Separation in LC is derived from the varying affinity of target analytes for the
phases in a column. This separation occurs in columns which can be an open tube or
packed with beads consisting of the same material as the solid stationary phase. The solid
stationary phase is an adsorbent that remains fixed to the inside of the column, and a
liquid mobile phase can be eluted through it. The varying affinity of a compound for the
stationary or mobile phase is what guides separation. The phases used in the most
common types of chromatography are of opposite polarity, so the order of elution for the
analytes in a solution depends on how polar they are. There are exceptions to this
however, such as hydrophilic interaction liquid chromatography (HILIC) which uses
mobile and stationary phases of the same polarity and separates with a more intricate
mechanism.
There exist several methods of liquid chromatography: the overarching types used are
normal phase and reverse phase. Normal phase chromatography employs a nonpolar
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mobile phase and a polar stationary phase. Highly nonpolar compounds

are pulled

through the column by the mobile phase rapidly with minimal retention to the stationary
phase. Reverse phase chromatography is similar in concept, but the mobile phase and
stationary phase are of opposite polarity from normal phase chromatography, with a polar
mobile phase and nonpolar stationary phase. Reverse phase columns typically consist of
silica functionalized with a long chain alkane, such as a C8 or C18 alkane. Mobile phase
solvents are typically polar, and include MeOH, ACN, and water. Order of elution in
reverse phase is different from normal phase, though generally the most polar compounds
elute first, and least polar elute last. The composition of the mobile phase can also be
adjusted over time through gradient elution to optimize separation and improve the
resolution and separation of the peaks. In many cases, the gradient must be adjusted to
ensure that compounds with high affinity for the stationary phase can elute, and analytes
with low affinity can still be retained in the column such that they all elute in the same
method. The mobile phase usually involves two solvents of opposite polarity, and by
starting with a high concentration of one solvent then slowly increasing the concentration
of the other solvent the polarity can be altered. This allows analytes that were strongly
interacting with the stationary phase to leave in favour of the mobile phase so they can
then be eluted. This lowers the retention time of the slow eluting analytes and improves
resolution, increasing the quality of the resulting spectra. Reverse phase liquid
chromatography is employed for much of this work as many of the target ESOCs are nonpolar and can be separated effectively in a reverse phase method.

1.4.1 HILIC
Hydrophilic interaction chromatography (HILIC) is a technique used in this work to
separate highly polar compounds. HILIC columns use a polar stationary phase and a polar
mobile phase to separate analytes that would elute early in reverse phase conditions and
may not be soluble in the nonpolar mobile phases used in normal phase chromatography.
The term was first used to describe a polar stationary phase with an aqueous-organic
mobile phase, and in that study, it was used in the separation of peptides, amino acids,
and other polar molecules.50 HILIC employs the varying hydrophilicity of polar
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molecules, as well as other electrostatic interactions with the stationary phase, to separate
these polar molecules from each other. The mobile phase in HILIC typically consists of a
mixture of ACN and water. In this mobile phase, water is more polar than ACN and
therefore adsorbs more effectively to the polar stationary phase (Figure 5).51 This
effectively turns water into a new stationary phase on the surface of the column, and
ACN acts more like a traditional mobile phase. When the analytes enter the column, the
more hydrophilic molecules enter the water layer and are retained, while the less
hydrophilic compounds continue to move through the mobile phase. Also, water and the
column stationary phase exhibit other electrostatic effects that differently retain analytes,
including hydrogen bonding and electrostatic effects on ionized functional groups. This
means that retention times for compounds in a HILIC column do not increase linearly
with hydrophilicity.52

Figure 5: Separation of layers in a particle in a packed HILIC column. Bare silica is
given as the stationary phase.53
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1.5 Mass Spectrometry
Following separation of target analytes in a liquid chromatography system, LC can be
coupled with mass spectrometry (MS) to then identify and quantify the compounds that
had been separated in the column. Tandem mass spectrometry is a valuable tool in the
identification and characterization of analytes in environmental samples as it can aid in
determining the identity of contaminants, and how much is in the sample. The separation
of target analytes in mass spectrometry is based on the mass-to-charge ratio (m/z) of an
ion, where units of mass are in daltons (Da), which are equivalent to 1/12 the mass of an
unbound carbon-12 atom.54 Analytes are ionized, then are broken into charged fragments,
where each compound typically has at least one product ion specific to the precursor ion
that is created by this fragmentation. The product ion varies based on the collision energy
(CE) specified by the method, and the optimal collision energy for fragmentation varies
for each compound. Most analytes are singly charged, giving a m/z value based on the
fragment’s atomic mass, though some larger analytes can be multiply charged, which
causes their m/z value to be a fraction of their atomic mass. Target analytes vary in both
their chemical structures and their properties, so different methods must be used to best
separate them such that detection of the compounds is as effective as possible.

1.5.1 Ionization
Ionization in a mass spectrometer generally occurs after liquid chromatography, and
before the target analytes are guided into the mass spectrometer. Heated electrospray
ionization (HESI) is the method of choice in this work, though many other forms of
ionization can be used depending on the purpose of the experiment. Solvents for HESI
typically include a mixture of water and a volatile organic solvent, like MeOH or ACN,
and often a weak acid or base to aid in ionization of the analytes, such as 0.1% formic
acid.55 HESI functions by aerosolizing droplets of solvent using heat and a strong electric
field (Figure 6).56 The solvent eluting from the column is injected into the ionization
chamber through a charged spray needle where it begins to form a stable liquid cone,
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called the Taylor cone (first described by Sir Geoffrey Ingram Taylor).57 In positive
mode, the source capillary is positively charged and the capillary leading to the mass
analyzer is negatively charged. Positively charged solvated analytes are expelled from the
source and are drawn towards the capillary outflow. Surface tension competes with
electrostatic forces, causing the characteristic shape of the Taylor cone with an excess of
positive charges on its surface. The Taylor cone begins to spray jets of liquid when the
surface tension of the cone is exceeded by the coulombic repulsion of the surface charge.
This phenomenon was first theorized by Lord Rayleigh in 1882 when estimating the
maximum charge a droplet could hold before throwing out fine jets of emission, and the
maximum surface tension is called the Rayleigh limit.58

Figure 6: General mechanism for electrospray ionization in positive mode. Positively
charged ions are selected and guided through to the mass spectrometer. The
ionization chamber is filled with nitrogen gas to aid in formation of droplets.

The droplets resulting from the electrospray evaporate spontaneously as they travel
towards the spectrometer. In positive mode, the droplets form with an excess of positive
charge, and are then guided towards the mass spectrometer. These larger droplets
evaporate as they move through the chamber, and once the repulsive charge in the droplet
exceeds the surface tension, the droplet breaks down further into smaller droplets until
they consist of only single ions. There exist three theories to explain the final production
of gas-phase ions in electrospray ionization. These are the ion evaporation model (IEM)
thought to be the method in which small molecules evaporate,59,60 the charged residue
model (CRM), which is used to explain evaporation of larger molecules,61 and the chain
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ejection model (CEM)62 which explains evaporation of unfolded proteins. Most of the
target analytes examined here are pesticides and pharmaceuticals, which are small
molecules, meaning CEM is not relevant in this case. It is generally accepted that both
IEM and CRM occur in tandem in evaporation, so both are applicable in this work
(Figure 7). In IEM, the electric field experienced by the droplet is sufficient to cause the
small molecules to eject from the surface of the solvent droplet as gas phase ions. In
CRM, the large molecule remains while the solvent droplets evaporate from the surface to
dryness. These methods explain how a target analyte adopts charge from the solvent
droplets resulting from jet emission and are valuable in this work to understand how
ionization is occurring in a mass spectrometer.

Figure 7: a) Ion evaporation model and b) Charged residue model used to explain
evaporation of solvent droplets to gas-phase ions in electrospray ionization.

1.5.3 Quadrupole Mass Filter
Once compounds have been isolated from their original complex mixtures and ionized, it
is now necessary to filter out just the analytes that are of interest. The quadrupole mass
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filter is a very important tool in spectrometry for selection of target analytes using their
mass-to-charge ratio. The quadrupole consists of four parallel rods, where rods on
opposite sides are paired. All four of the rods receive the same voltage, but the pairs have
opposite signs. Direct current remains consistent, while alternating current is applied to
the rods at radiofrequency (rf) voltages. These alternating currents form an electric field
that is able to guide molecules through the quadrupole. This oscillating field can be
modified to select ions of one specific m/z or a range of m/z values that will maintain a
stable trajectory. Ions that are smaller than this m/z are destabilized too much by the field
and are ejected out of the quadrupole, ions larger than this m/z are not affected enough,
and are similarly ejected upon collision with the rods (Figure 8).

Figure 8: Example trajectories of ions entering a quadrupole mass filter. The front
pole is omitted to observe the ion pathway at the centre of the quadrupole.

1.5.3 Fragmentation
Following selection of the target ions, fragmentation is performed to break the ion into
fragments such that a unique pattern of fragmentation occurs. Putative identification can
occur when the resulting fragmentation pattern is compared to literature or previous
scans. When this is paired with the retention time (RT) from LC, we can confidently
determine the identity of the original ion. Fragmentation in mass spectrometry involves
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collision with an inert gas, such as argon, helium, or nitrogen gas. The two mass
spectrometry methods used in this work use two different types of collision for
fragmentation of the target analytes. In an Orbitrap mass spectrometer, higher-energy
collisional dissociation (HCD) is used in an HCD collision cell. This cell is aligned
perpendicular to the Orbitrap mass analyzer, and the ions are guided in by a
radiofrequency-only quadrupole. HCD is a variation of collision-induced dissociation
(CID), where the ions collide with an inert gas to break into pieces, and in HCD this
occurs outside of the ion trap. The collision causes fragmentation by converting kinetic
energy to internal energy to break bonds between atoms. Upon fragmentation, the ions
accumulate in the C-trap until either the maximum number of ions set by the method has
accumulated, or until a specified time has elapsed, whereupon all ions are injected into
the Orbitrap mass analyzer simultaneously for analysis. In triple quadrupole mass
spectrometry, CID is used, and it occurs in the second quadrupole which employs only
radiofrequency to guide the analytes through the collision cell. Collision energy in both
cases can be modified based on the analyte, as the energy at which the analytes collide
with the inert gas can alter the fragmentation of the target. Collision must be optimized
based on the target, as too little energy will not cause sufficient fragmentation, and too
much energy will cause the analyte to fragment into too many pieces, and the product ion
will not be characteristic of the precursor.

1.5.4 Orbitrap Mass Spectrometry
Detection of analytes in a complex mixture is often difficult, and there is an everincreasing list of compounds to detect. The Orbitrap mass spectrometer is a powerful
HRMS instrument used for a variety of environmental analyses due to its ability to
analyze a wide range of analytes at the same time.63 A simplified overview of a Qexactive Orbitrap mass spectrometer is shown in (Figure 9).64 When paired with liquid
chromatography, the compounds that are eluted from the column are ionized as
previously described via HESI and are directed into the spectrometer. The instrument is
under vacuum, and the ions are pulled in by vacuum electronic-field forces, then the Slens uses radiofrequency to focus them into a beam and direct them into the instrument.
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Upon entering the instrument, the analytes are guided through the bent flatapole, where
the electric field in the flatapole sends charged ions into the quadrupole mass filter. Due
to the bend in the flatapole, neutral atoms and solvent droplets are not guided by the
electronic field and are removed at the bend. Ions that make it through the bent flatapole
are then focused into the quadrupole mass filter which employs both rf and direct
currents to guide ions through. Ions are then selected in the quadrupole mass filter as
described above.

Figure 9: Simplified schematics of a Q-ExactiveTM Orbitrap mass spectrometer.

Upon exiting the quadrupole mass filter, the ions are guided through into a curved linear
trap (C-trap). In this C-trap, the ions begin to accumulate until they are either injected into
the HCD cell or the Orbitrap mass analyzer. Analytes can be injected into the Orbitrap
mass analyzer intact, or can be injected into the HCD cell for fragmentation. Ions that
enter the HCD cell are fragmented as described above against inert gas. Once fragmented,
the product ions accumulate in the C-trap before being injected simultaneously into the
Orbitrap mass analyzer. The Orbitrap mass analyzer consists of two outer electrodes
surrounding a spindle-shaped central electrode.64,65 In the Orbitrap, ions separate by m/z
based on their trajectory in the radial and axial directions (Figure 10). Ions in the
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Orbitrap oscillate and begin to form stable trajectories in bands characteristic of their m/z.
The frequency at which these ions oscillate around the electrode depends solely on their
m/z, so a mixture of ions will separate into different trajectories, and these frequencies
can be detected by the outer electrodes. Through a Fourier transform of the detected
signal, the m/z of all ions in the mass analyzer can be detected.

Figure 10: Simplified diagram of an Orbitrap mass analyzer. Trajectory of an
example ion is expressed as a red line. The radial (R) and axial (Z) directions are
labelled.65

The utility of an Orbitrap mass spectrometer is in its ability to be used for nontargeted
analysis methods on a complex mixture. These methods vary based on how they collect
data from an injected sample, and can be chosen based on the intended result. For
example, all ion fragmentation (AIF) is a method in which all the available precursor ions
are fragmented and injected into the Orbitrap mass analyzer simultaneously. AIF
produces complicated spectra, especially when analyzing a mixture of compounds, which
leads to difficulty in identification of each individual peak. A more specific method of
detection that produces comparable results with less noise is data dependant acquisition
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(DDA). DDA limits fragmentation of ions to those that appear above a selected level of
abundance. This is useful in detecting the most prominent compounds in a mixture or
sample, as no compounds below the set abundance will be injected into the mass
analyzer.66 One important drawback of AIF and DDA for this work is that trace analysis
is not possible. Because DDA would not select trace contaminants, and AIF would be too
difficult to deconvolute and determine the precursor and product ions, neither method is
able to detect many compounds that are present in low concentrations.
For nontargeted environmental analysis one valuable method is data independent
acquisition (DIA), a method designed around the capabilities of the Orbitrap and C-trap
to perform trace analysis of a complex mixture. This method involves separating the
scans into mass ranges, then fragmenting and analyzing all ions in those windows. This
differs from AIF however, in that smaller ranges of the precursor ions are transmitted at
one time, allowing for much easier identification of the resulting fragment.67 The
precursor ions in DIA are divided into low mass, medium mass, and high mass windows
of 128-351 m/z, 349-651 m/z, and 649-1051 m/z. The slight overlap in the m/z window
ensures that product ion data are collected for every ionizable compound in the mixture.
The spectra produced from this method can also be stored and retrospectively analyzed to
identify any new analytes of interest in the future.

1.5.5 Triple Quadrupole Mass Spectrometry
Much environmental analysis employs a triple quadrupole mass spectrometer (QqQ)
paired with high-performance liquid chromatography (HPLC) to examine contaminants.
By employing three quadrupoles in succession68, a QqQ instrument can accurately
separate and quantify these contaminants from an environmental sample containing many
different analytes (Figure 11). QqQ methods can vary based on the type of analysis to be
performed. There are several scan modes used in QqQ: precursor ion scan, neutral loss
scan, product ion scan, selected reaction monitoring (SRM) and multiple reaction
monitoring (MRM).69 For the purposes of the environmental analysis in this work, MRM
is the method used. In MRM, the first and third quadrupole are used as mass analyzers set
to select for the m/z of many different parent and product ions. By rapidly switching
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between these pairs of parent and product ions, multiple fragmentation patterns can be
detected. This enhanced selectivity of the instrument is possible with minimal loss in
sensitivity, making it especially effective in trace analysis of environmental contaminants,
where concentrations are typically low. As described above, the second quadrupole is
where fragmentation of the precursor occurs.

Figure 11: Triple quadrupole mass spectrometry setup overview for multiple
reaction monitoring.68

QqQ is especially effective in determination of environmental samples, as many of the
matrices in this work are complex and contain a wide variety of organic compounds.
When multiple compounds co-elute, their interactions can cause the retention time of an
analyte to shift away from its expected value. These matrix effects can cause either a
suppression or an enhancement of the ionization, which are a constant struggle in
identification and quantification of compounds in mass spectrometry. The selectivity of
MRM enables a QqQ instrument to overcome matrix effects, making it especially utile
for biosolids analysis. Much of the work in this thesis uses a targeted analysis method
with a QqQ instrument with an extensive target list. Due to the excellent selectivity of the
instrument and the large target list of important environmental contaminants, QqQ is the
best instrument to use for the purpose of this research.

1.6 Thesis Objectives
The overall objective of this thesis is use mass spectrometry to investigate environmental
contamination, its extent, and the avenues in which it occurs. Chapter 2 elaborates on the
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compounds of interest metformin and guanylurea and their occurrence in Ontario and
Quebec surface water and sediment. Chapter 3 discusses treatment of biosolids with a
thermal hydrolysis chemical treatment to create fertilizer, and the effects of this treatment
on ESOC concentration. Chapter 4 discusses the use of methods for extraction of various
ESOCs from surface water. Solid phase extraction is used to analyze water for a wide
variety of environmental contaminants using one method. The resulting data from this
method should provide insight into what compounds are most common contaminants in
the environment. The data can be stored and retrospectively analyzed to determine long
term temporal trends for a wide variety of ESOCs across Ontario and Quebec.
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Chapter 2
Investigation of the Diabetes Medication Metformin and its
Degradation Product Guanylurea in Ontario and Quebec
watersheds using Mass Spectrometry

27

2.1 Chapter 2 Objectives
Metformin and guanylurea are two common environmental contaminants found around
the world. Metformin has been in use for decades as a diabetes medication, and it has
recently been proven that guanylurea is created when metformin is bacterially degraded.
The goal of this study is to identify and quantify both compounds in the environment
using multiple years of stored surface water and sediment samples. Using this
information, it can aid in elucidating the origins of the compounds in the environment,
and how prevalent they are across Canada.

2.2 Introduction
2.2.1 Metformin
One particular pharmaceutical of interest in this work is metformin. Metformin is a smallmolecule drug used as a first-line medication in treatment of type 2 diabetes. First
discovered in 192970, metformin and other similar biguanide derivatives were not
investigated for their hypoglycemic effects in humans until the late 1950s71. This was due
to the ground-breaking discovery of insulin, for which Sir Frederick Banting won the
Nobel prize in 1923, and insulin became one of the first and most well-known compounds
used in treatment of diabetes. Due to the increasing availability of insulin, hypoglycemic
drugs such as metformin were generally forgotten about until the 1940s where metformin
was rediscovered in a search for antimalarial drugs72,73. The antimalarial biguanide drug
proguanil was modified to metformin, which was then used in the Philippines to treat
influenza. Metformin hydrochloride was prescribed under the name fluamine, where its
ability to lower blood glucose was also noted.74 Following the rediscovery of the
hypoglycemic effects of biguanides, the 1950s saw three clinical trials performed on three
separate biguanides by different laboratories. The compounds tested in these trials were
metformin under the name Glucophage (“glucose eater”) by Jean Sterne in France75,
buformin by Mehnert et al. in Germany76, and phenformin by Ungar et al. in the United
States77 (Figure 12).
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Figure 12: Structures of the initially investigated biguanide drugs a) Metformin, b)
buformin and c) phenformin

All three of the investigated biguanides exhibited similar effects. Though the exact
mechanism was not known at the time, it has since been discovered that activation of
AMP-activated protein kinase is required to exhibit the glucose lowering effects78,79.
Through this interaction, each of the drugs inhibit gluconeogenesis in the liver and
promote uptake of insulin through the cell membranes. One important drawback to
buformin and phenformin is that their longer alkyl chains make them more lipophilic and
therefore less prone to metabolism. This characteristic means that patients receive
prolonged exposure to the compounds when compared to metformin, and the clinical
trials were ended due to an increase in the side effect of lactic acidosis, causing
phenformin and buformin to be withdrawn from most countries in the 1970s.80,81 Lactic
acidosis is a buildup of lactic acid in the blood and is a possible side effect of all
biguanides as they inhibit the formation of new glucose from lactate through
gluconeogenesis. Metformin is known to cause lactic acidosis, but it is much less
common and is mostly an issue in patients with existing kidney impairment, as roughly
80% of metformin is excreted by the kidneys.82,83 When the kidneys are impaired, they
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are unable to efficiently excrete metformin and prolonged action of the drug then causes
this buildup of lactic acid, which can be fatal.
Metformin has been available in the UK since 1958 and Canada since 1972 but was not
approved by the Food and Drug Administration (FDA) until 1994 due to lingering
concerns around toxicity of phenformin, which had been used widely before its
withdrawal. Many studies were performed to investigate the impact of clinical use of
metformin, and following its approval, a study was published in the New England Journal
of Medicine confirming the efficacy of metformin in treatment of diabetes mellitus.84
Since then, it has become the most common oral drug prescribed for treatment of diabetes
in the world. Further investigation of metformin has also revealed that it is useful in
treatment of several other maladies, including polycystic ovary syndrome (PCOS),85
cancer,86,87 and COVID-19.88 Prescriptions of metformin increase annually both with the
increasing human population, and the new illnesses in which it is finding use. The total
prescriptions of metformin surpassed 120 million worldwide in 201289, and have been
increasing ever since.90 Metformin is a pharmaceutical that is excreted mostly unchanged
from the body, and many WWTPs do not sufficiently degrade it15,91, so this widespread
usage may cause significant contamination.

2.2.2 Guanylurea
One important subsection of ESOCs that has been less extensively researched is their
degradation products or metabolites. Both pesticides and pharmaceuticals can be
degraded environmentally. Whether this is instigated by bacteria, UV, heat, pH, or some
other pathway, the original compound is broken down into a different form. Due to the
constant replenishment of ESOCs in the environment from WWTPs and agriculture, it is
possible that their degradation products are accumulating in surface water or sediment.
This could be hazardous if these degradation products exhibit any notable toxicity. This is
of increasing importance for metformin as its usage has been widespread for decades and
its degradation product guanylurea was only discovered relatively recently.92,93
Guanylurea arises from the degradation of metformin when exposed to certain bacteria, at
least one of which belonging to the species Aminobacter has been isolated.94 The exact
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mechanism of degradation is not known, though spectral data indicate two dealkylations
and an oxidative deamination93 occur to form guanylurea from metformin (Figure 13).

Figure 13: Chemical structures of a) the pharmaceutical metformin and b) its main
metabolite guanylurea

2.2.3 Contamination and Toxicity of Metformin and Guanylurea
The prominence of metformin and guanylurea in the environment is due to the inability of
WWTPs to fully degrade complex pharmaceuticals. As metformin is an important
chemical in diabetes treatment and is commonly prescribed around the world, it has been
identified in waterways in many countries, including Canada,2,95 the United States,2,96,97
Greece,98 the Netherlands,99,100 Germany,21,93,101 and China.102 In areas with a higher
number of metformin prescriptions, higher concentrations of metformin in the
surrounding surface water have also been noted. This may indicate that as the world
population increases, metformin prescriptions and therefore environmental concentrations
may increase as well.
Studies have examined the change in concentration from WWTP treatment and noted that
in some cases the concentration of guanylurea increases from influent to effluent
corresponding to a decrease in metformin concentration. Some other cases, however, did
not note any change in metformin concentration. This is evidence that degradation of
metformin results mainly in the formation of guanylurea, and that only certain bacterial
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species that are not always present in WWTPs are able to perform this degradation. 92–94
After the discovery of guanylurea, retroactive studies of water samples containing
metformin found guanylurea in the same samples where it had not been previously
detected.92
In March of 2022, a study determined that metformin may be responsible for genital birth
defects in human males when the father was prescribed metformin103. Metformin exposed
children were more likely than the control group to exhibit birth defects, and further
research is being conducted to determine the severity of these findings. One different
study noted increases in childhood obesity for children whose mothers had been
prescribed metformin to treat PCOS.104 These toxic effects were only discovered recently
despite the long-term use of the drug, so there may be as of yet undiscovered toxic effects
occurring in the environment as well.
One important set of toxicological studies performed by Environment and Climate
Change Canada (ECCC) identified toxic effects on the Japanese medaka (Oryzias
latipes).105–107 When exposed to concentrations of guanylurea lower than 0.25 µg/L for
their whole life cycle, Ussery et al. noted intersexuality in juvenile male fish, as well as
negative effects on growth and total body length. The study is especially relevant to this
work as environmental concentrations we have observed can reach and exceed the
concentrations at which these effects occur.98,99 Typical toxic concentrations of
metformin or guanylurea for many organisms are not seen to be as close to the toxic
concentrations below 0.25 µg/L of guanylurea on Japanese medaka as identified by
Ussery et al.. It is important, however, to know toxic concentrations for as many other
organisms as possible to attempt to extrapolate that information to similar organisms and
more easily eliminate sources of contamination in the environment. Several aquatic
organisms and the toxic concentrations of metformin and guanylurea at which effects
begin to occur are listed in Table 1.
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Table 1: Literature concentrations of metformin and guanylurea that exhibit effects
on aquatic organisms
Organism

Concentration

Effects

Fathead minnows (Pimephales
promelas)108

40 µg/L Metformin

Intersexuality and Weight
loss

Japanese Rice Fish (Oryzias
latipes)48

10 µg/L Metformin

Weight and length decrease

Japanese Rice Fish (Oryzias
latipes)105

>0.25 µg/L Guanylurea Weight and length decrease

Freshwater Plankton (Daphnia
magna)91

EC50 40 mg/L
Guanylurea

Immobilization

Duckweed109 (Lemna minor)

EC50 24.2 mg/L
Metformin

Growth Inhibition

Water fleas109 (Daphnia similis)

EC50 14.3 mg/L
Metformin

Immobility

Siamese Fighting Fish110 (Betta
splendens)

40 µg/L Metformin

Decreased Aggression

Although ecotoxicological data are minimal for both compounds, it is advantageous for
scientists and regulatory agencies to know typical environmental concentrations of these
contaminants. This allows for investigation into the effects of environmentally relevant
concentrations on aquatic organisms that may be exposed to them. We hypothesized that
the concentrations of compounds depend primarily on the location of the sampling, with
the highest concentrations of both metformin and guanylurea occurring near the influence
of sewage/wastewater treatment effluents, with lower concentrations in agriculturally
dominated landscapes where fertilizers are applied to fields. We believe that the data
presented here will help us to better understand how both compounds behave in impacted
water resources and sediment, help us untangle pollution sources, and determine where
and when concentrations could be of concern from a toxicological perspective.
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2.3 Methods
2.3.1 Surface Water
Water samples were taken in monthly intervals from May to November from 2018 to
2020 by the conservation authorities at each of the watersheds studied. One-litre
polyethylene terephthalate (PET) bottles (SystemsPlus, Baden, ON, CA) were filled at the
sampling site using a pole sampler. Filled bottles were then stored on ice in insulated
coolers and shipped to Agriculture and Agri-Food Canada (AAFC) at the London
Research and Development Centre (LRDC). Samples were logged and stored at -20°C
until ready for analysis. Prior to the monitoring program, unpublished stability studies
determined metformin and guanylurea are stable under these conditions and will not
degrade before simultaneous analysis. Monthly sampling over three years allows for
long-term analysis of each site and is more accurate in assessing risk of the compounds
by determining an average concentration that organisms at each site are exposed to over a
prolonged period.
Surface water samples were analyzed by a Thermo Vanquish™ Duo tandem UHPLC
system coupled to a TSQ Altis™ triple quadrupole mass spectrometer (Thermo Fisher
Scientific, Waltham, MA, USA). Sample vials were stored in an autosampler at 10 °C and
10 µL were injected onto one of two Agilent Zorbax Eclipse Plus columns (2.1 x 50 mm,
1.8 µm, Agilent Technologies, Santa Clara, CA, USA) maintained at 35 °C with a flow
rate of 300 µL/minute. Mobile phase A (H2O + 0.1% FA; Optima LC-MS Grade) (Fisher
Scientific, Lawn, NJ, USA) was held at 2% for 0.750 minutes. Mobile phase B
(acetonitrile + 0.1% FA; Optima LC-MS Grade) (Fisher Scientific, Lawn, NJ, USA) was
then increased to 15% over 1.05 minutes and to 24% over 5.6 minutes. Finally, mobile
phase B was increased to 98% over 15.1 minutes and held for 2.4 minutes. While analytes
were being resolved on one column, the second column was re-equilibrated for 3.5
minutes at 300 µL/minute mobile phase A in preparation for the subsequent injection.
The OptaMax NG HESI source was operated with capillary voltages of 3.5 kV in both
positive and negative mode, ion transfer tube temperature of 325 °C and vaporizer
temperature of 350 °C. The sheath, auxiliary and sweep gases were set to 35, 10, and 1
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arbitrary units, respectively. Quantification was performed in Thermo TraceFinder 5.0
(Thermo Scientific, Waltham, MA, USA).

2.3.2 Sediment
Sediment samples were collected in 2020 at the same sampling sites the surface water
was collected. A stainless-steel scoop was cleaned with MeOH and used to take sediment
samples which were then placed in 500-mL PET bottles (SystemsPlus, Baden, ON, CA).
Samples were stored in insulated coolers on ice and shipped to the LRDC, then were
frozen alongside surface water samples at -20°C. Previously performed unpublished
stability tests confirmed that metformin does not degrade to guanylurea under these
conditions, so concentrations of guanylurea calculated in the samples are due only to its
original occurrence in the sample. For the sediment extractions, roughly 3-4 g of wet
sediment from each site was weighed into a 15-mL conical polypropylene (PPE) Falcon
tube. Each tube was centrifuged for 10 minutes at 4000 rpm in an Eppendorf 5810R
benchtop centrifuge (Eppendorf, Mississauga, ON, CA) before carefully decanting water
from the sediment. Each tube was then weighed to determine the mass of the remaining
sediment. The sediment samples were air-dried for 90 minutes prior to extraction. A 10
µg/mL metformin-

13

C4

15

N5 and guanylurea-15N4 (Sigma Aldrich, St Louis, MO, USA)

internal standard spiking solution was added to the sediment at a ratio of 10 µL/2.5 grams
to simulate 40 ng/g of IS in sediment. Based on the protocol of Ostensvik et. al,41 the
spiked sediments were extracted using 6 mL of extraction buffer consisting of 1:9 formic
acid:0.5 M ammonium acetate (Sigma-Aldrich, St Louis, MO, USA) for every 2.5 g of
sediment. The solutions were vortexed for 30 seconds on a Vortex-Genie 2 model G-560
(Scientific Industries, Bohemia, NY) to ensure the sediment material was completely
dislodged from the base of the Falcon tube. The sediments were sonicated at room
temperature in a Cole-Parmer ultrasonic cleaner (Cole-Parmer, Vernon Hills, IL, USA)
for 20 minutes then vortexed for 30 seconds. Samples were then placed in a tube rack on
a VWR DS-500 orbital shaker (Avantor, Radnor, PA, USA) operating at 400 rpm for 30
minutes at a 45° angle to assist with mixing. Following this, the tubes were centrifuged at
4000 rpm for 10 minutes to separate the solid and liquid layers. The top liquid layers were
then carefully decanted into clean 15-mL tubes and spiked with an IS of 10 µg/mL
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metformin-D6 at the same volume as the original metformin15

13

C4

15

N5 and guanylurea-

N4 IS spike to simulate the same 40 ng/g concentration. From these extracts, 500 µL of

each was removed and placed into an amber HPLC vial (Agilent Technologies, Santa
Clara, CA). The solutions were dried with a gentle stream of nitrogen and reconstituted in
250 µL H2O, then 250 µL of acetonitrile. This dry down step is important due to the high
concentration of formic acid used in the extraction buffer which leads to poor separation
in the chromatogram. The 500-µL reconstituted extracts were vortexed for 30 seconds to
ensure dissolution of the solids, then placed into the HPLC autosampler. The initially
spiked IS mixture of metformin- 13C4 15N5 and guanylurea-15N4 underwent the extraction
method and as extraction efficiency is not 100%, the peak height was diminished. The
post-spike metformin D6 was not diminished because it was added to the final extract,
therefore recovery efficiency (RE%) can be calculated by comparing the peak heights of
the two analytes.
All samples were analyzed by a Q-Exactive Orbitrap mass spectrometer (Thermo Fisher
Scientific) coupled to an Agilent 1290 HPLC. A 2-µL sample was injected onto a Waters
BEH amide column; (2.1 x 50mm, 1.7 µm) maintained at 35 °C with a flow rate of 400
µL min-1. Mobile phase A (10 mM ammonium formate with 0.1% formic acid in water:
acetonitrile, 1:9) was held at 100% for 1 minutes. Mobile phase B (10 mM ammonium
formate with 0.1% formic acid in water) was then increased to 5% over 1 minutes and to
50% over 0.6 minutes. Mobile phase B was held at 50% for 1 minute before returning to
0%. The column was re-equilibrated with mobile phase A for 2 minutes prior to the
subsequent injection. The HESI-II source was operated in positive ionization mode with
capillary voltages of 3.5 kV, ion transfer tube temperature of 400 °C and vaporizer
temperature of 300 °C. The sheath and auxiliary gases were set to 25 and 8 units,
respectively. Target analytes and their corresponding internal standards were monitored
using the settings listed in Table 2. Quantification was performed in Thermo Xcalibur
platform version 4.3 with a mass accuracy of 5 ppm and RT window of ± 0.05 minutes
relative to the internal standard.
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2.3.3 Quantification
Quantification using internal standards (IS) is an accurate method for determining
quantities of metformin and guanylurea in surface water and sediment. Labelled standards
use stable isotopes in place of several atoms on the analyte such that the same
fragmentation patterns and characteristics are the same, but the m/z is slightly different. In
the case of the metformin and guanylurea IS,

15

N,

13

C, and deuterium (2H or D) are all

used. The internal standards are spiked into the solution at a known concentration which
enables a simple comparison of the responses from the known concentration of IS and the
unknown concentration of metformin and guanylurea already present in the sample.
In the sediment extraction method, samples were spiked with two different IS mixtures.
The first mixture, added before the extraction, contained metformin-

13

C4

15

N5 and

guanylurea-15N4. This mixture allows for quantification of the unknown amount of
metformin and guanylurea by calculating the ratio of the peaks of our unknown
concentration to our known concentration of the internal standard. The second internal
standard of metformin-d6 was spiked after the extraction method at the same
concentration of the initial mixture. The recovery can then be determined by comparing
the peak height of metformin-d6 to metformin-13C4 15N as the only loss of signal would be
due to the recovery efficiency, and signal suppression or enhancement in the method.
Internal standards used are metformin-

13

C4

15

N5, guanylurea-15N4, and Metformin-D6

which were detected using the mass spectrometer settings outlined in (Table 2).
Table 2: Mass Spectrometer settings for Metformin, Guanylurea, and related
Internal Standards
Analyte
Metformin
Metformin
(13C4,15N5)
Metformin (D6)
Guanylurea
Guanylurea
(15N4)

Ion
Type
[M+H]+

RT
(min)
2.24

Precursor
m/z
130.1

Collision
Energy (NCE)
42

Quantifier
ion m/z (CE)
60.0564

Qualifier ion 1 m/z
(CE)
71.0610

[M+H]+

2.24

139.1

42

64.0508

-

[M+H]+
[M+H]+

2.24
2.12

136.1
103.1

42
21

60.0564
60.0563

86.0355

[M+H]+

2.15

107.1

21

63.0474
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2.4 Results and Discussion
2.4.1 Surface Water and Sediment
Quantification of metformin and guanylurea at each sampling site revealed the
widespread occurrence of both compounds. In surface water, each of the six individual
watersheds registered guanylurea at every site at least once, and metformin in all but two
of the 40 total sites. Metformin was identified above the limit of detection (10 ng/L) in
51.0% of samples, and guanylurea above the limit of detection (LOD) (100 ng/L) in
50.7% of the 673 total samples. Despite the LOD being a magnitude higher for
guanylurea, it was only detected in two fewer surface water samples, meaning guanylurea
would likely be present in many more samples if the LODs were lower. Metformin was
found in 343 different samples, and guanylurea was found in 71.4% of them. In water
samples in which both compounds appeared, guanylurea was higher in 89.0%, or 218 out
of 245. Guanylurea was also found above the LOD in 104 samples where metformin was
not found. These factors are both indicative of degradation of metformin leading to
increasing concentrations of guanylurea in surface water. In 70 of the 98 samples where
guanylurea was not found, metformin was found at concentrations below 100 ng/L,
meaning the initial presence of metformin may not have been sufficient for detectable
concentrations of guanylurea to appear.
For sediment analysis, samples were taken only in 2020 from sites in which it was safe to
do so. From the 40 surface water sampling sites, sediment was taken from 29 of them for
a total of 155 samples. In these samples, metformin was extracted and detected above the
limit of quantification (0.05 ng/g metformin and 0.6 ng/g guanylurea) in 98 of them. Of
the 155 samples, there were 56 samples which registered neither compound. Metformin
and guanylurea appeared in the same sample in 26 of the 30 samples that contained
guanylurea. Conversely to the trends observed in surface water, guanylurea was found
both in fewer samples, and in much lower concentrations than metformin. Previous
studies have analyzed the sorption of metformin and guanylurea to sediment and have
determined that their solubilities are high, and binding to sediment is weak.6 As few sites
did measure metformin and guanylurea through the sampling period, this is reinforced by
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the data. Average concentrations of metformin and guanylurea calculated in surface water
and sediment for all sites are listed in Table A1 and Table A2, respectively.
To best compare the concentrations of metformin and guanylurea in surface water and
sediment between sites in the same watershed, ratios of metformin and guanylurea are
plotted on maps of the sampling site locations (Figures 14-20). The average
concentrations of metformin and guanylurea were calculated in samples in which they
were detected, and samples below the LOD are omitted in calculations. Average
concentrations during the sampling period are expressed as a pie chart, and the size of the
pie chart increases with the total concentration of the two compounds at the sampling site.

2.4.2 Ausable Bayfield Results
The Ausable Bayfield Conservation Authority (ABCA) samples the Ausable Bayfield
watershed, which lies along Lake Huron and includes cities such as Grand Bend and
Goderich. Ausable Bayfield is one of the less populated watersheds investigated in this
work with a population of roughly 45000.111 Its area is 2440 km2, most of which is
agricultural areas. The sampling sites investigated are therefore influenced mostly by
agriculture, and the human input in the region should be minimal compared to more
populous watersheds (Table 3).
Table 3: Activity and Input at ABCA sampling sites
Sampling Site

Primary Activity

A1

Human input

A2

Agriculture

A3

Agriculture

A4

WWTP

The primary expected sources of both metformin and guanylurea in the environment are
urban influences and WWTPs. As there were limited urban influences at this watershed,
and the only WWTP was from a small human population, overall concentrations of
metformin and guanylurea were quite low (Figure 14). In surface water, the highest
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average concentration of metformin at any of the sites was 0.040 ± 0.03 µg/L at site A4,
and the highest concentration of guanylurea was 0.313 ± 0.5 µg/L at site A3. These
concentrations are much lower than those known to cause toxic effects, even with chronic
exposure. In sediment, concentrations of metformin and guanylurea were low as well.
Site A1 only registered metformin on one occasion through the sampling period, and it, as
well as A4, did not contain guanylurea in sediment even once. Guanylurea was not more
prevalent in the other sites either, as both A2 and A3 registered it only once through the
six-month period. The highest concentration recorded in the watershed was 133.05 ng/g
in June 2020, while no other samples taken in the following months from the same site
were over 5 ng/g. This may indicate that metformin in this region is not persistent, and
degrades over time to guanylurea, or resolubilizes and dilutes around the watershed.

Surface Water
- Metformin
- Guanylurea

A1
A3

Sediment
- Metformin
- Guanylurea

A2
10 µg/L or 100 ng/g
1 µg/L or 10 ng/g
0.1 µg/L or 1 ng/g

A4
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Figure 14: Site map for the Ausable Bayfield watershed. Ratios of metformin to
guanylurea at each site are provided as pie charts, the size of the pie chart increases
with total concentrations of both compounds.

2.4.3 Cedar Results
The Essex Region Conservation Authority (ERCA) samples from the Cedar watershed
which encompasses the southwestern most tip of Ontario and includes sites along Lake
Erie and Lake St. Clair near the Detroit River. Both Detroit and Windsor are cities near
these sampling sites with a heavy manufacturing presence. The population in this region
is relatively high at over 420 000 people,112 so human input in the area is a significant
factor. Four distinct types of inputs are examined in this watershed, one WWTP, one
urban, one greenhouse, and two agriculture influences (Table 4).

Table 4: Activity and Input at ERCA sampling sites
Sampling Site

Primary Activity

C1

WWTP

C2

Greenhouse

C3

Agriculture

C4

Agriculture

C5

Urban

The highest combined concentration identified in this watershed was 4.55 µg/L at C1,
where an average of 4.20 ± 7 µg/L of guanylurea was measured in 2018-2020. C1 is
sampled near a WWTP, so it is expected to exhibit higher concentrations of
pharmaceuticals, and it is the only site to average over 1 µg/L guanylurea. Every sampled
site in this watershed measured an average concentration of guanylurea in surface water
higher than the benchmark for chronic toxicity of 0.25 µg/L as highlighted by Ussery et
al. in 2019. Variation in concentration between timepoints is large however, as all 2020
samples at C1 registered over 0.25 µg/L, while only one sample in 2018 contained
guanylurea at all. This may indicate increased use of the compound and therefore
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increasing risk of accumulation of guanylurea in the environment. C1 was also the only
site to not only have an average over 1 µg/L, but to register above that level in any of the
samples taken through all three sampled years.
Fewer sites in this watershed were able to be safely sampled for sediments. Similarly to
the Ausable Bayfield watershed, guanylurea was found much less frequently in sediment
than guanylurea, appearing only once in B3 and nowhere else at any point. The
concentration of guanylurea found at this site was also much lower than the average
concentrations of metformin, at 2.93 ng/g guanylurea. Of the 10 samples in which
metformin was found through the sampling period, only one sample was lower than 2
ng/g. All three of the sites had low concentrations of guanylurea but had an average
concentration of over 20 ng/g metformin (Figure 15). This indicates that guanylurea does
not adsorb as effectively to soil as metformin, and that accumulation in soil is not
occurring extensively at this watershed.
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10 µg/L or 100 ng/g
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Figure 15: Site map for the Cedar watershed. Ratios of metformin to guanylurea at
each site are provided as pie charts, the size of the pie chart increases with total
concentrations of both compounds.

2.4.4 Upper Grand Results
The Grand River Conservation Authority (GRCA) samples the Grand River watershed
containing the cities of Kitchener, Waterloo, Guelph, Brantford, and Cambridge, as well
as several other smaller communities. The Grand River watershed is the largest watershed
in Ontario at 6800 km2, with a total population of over 1 million people, most of whom
live in the larger cities.113 Two sampling sites are sampled near Kitchener and Waterloo
and are influenced primarily by WWTPs in the region, while the rest are further from the
larger cities and receive input mostly from agriculture (Table 5). The more populous
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regions are expected to exhibit the highest concentrations of metformin and guanylurea in
surface water especially due to the nearby WWTP effluents that receive input from the
surrounding population.
Table 5: Activity and Input at GRCA sampling sites
Sampling Site

Primary Activity

UG1

WWTP

UG2

Rural

UG3

Agriculture

UG4

WWTP

UG5

Agriculture

UG6

Agriculture

Of the six sites with different activities, the highest recorded concentrations of both
metformin and guanylurea occurred at the WWTP sites near Kitchener and Waterloo:
UG1 and UG4. This is due to the higher populations leading to increased use of the
compounds in the area, and the main source in the watershed being WWTP effluent. Both
UG1 and UG4 contained average concentrations of guanylurea higher than 2 µg/L, at
2.82 ± 2 µg/L and 2.01 ± 1 µg/L, respectively. Out of 16 samples taken from each of UG1
and UG4 through the three-year sampling period, 14 contained over 0.7 µg/L of
guanylurea in both. For both sites, the samples that contained below 0.7 µg/L were all
from 2018. These concentrations are well above concentrations that can cause toxic
effects in Japanese medaka, so there may be toxic effects already occurring to organisms
in the region.
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Sediment data for the Upper Grand region follow similar trends to those observed in the
previous watersheds. Guanylurea was found twice at UG6, and was found only once at
each other site. The highest single occurrence of 1.99 ng/g guanylurea was at UG1 in
May 2020, where the concentration of metformin at the same timepoint was found to be
34.857 ng/g. Repeating the previous trends, metformin was more common in sediment
samples than guanylurea, and was in higher concentrations (Figure 16).

10 µg/L or 100 ng/g
UG2

1 µg/L or 10 ng/g
0.1 µg/L or 1 ng/g

UG5

Surface Water
- Metformin

UG3

- Guanylurea
Sediment
- Metformin
- Guanylurea
UG6
UG4
UG1

Figure 16: Site map for the Upper Grand watershed. Ratios of metformin to
guanylurea at each site are provided as pie charts, the size of the pie chart increases
with total concentrations of both compounds.
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2.4.5 Upper Ottawa – Kipawa Results
The Organisme de Bassin Versant du Témiscamingue (OBVT) is at the remote region of
Upper Ottawa- Kipawa, located along the border of Northern Ontario and Quebec. The
watershed is quite small, with a total population of roughly 59 000 and a population
density of only 1.7 inhabitants/km2.114 One important site in this watershed is site 6,
which was the only site in the dataset that was sampled directly from the effluent pipe of
a WWTP (Table 6). As these water samples have not had time to dilute and diffuse about
the watershed, UOK site 6 should contain the highest concentration of all chemicals in the
watershed that result from WWTP contamination. Sampling in this watershed only
occurred in 2020, so long term data are not available.

Table 6: Activity and Input at OBVT sampling sites
Sampling Site

Primary Activity

UOK1

Agriculture

UOK2

Agriculture

UOK3

Agriculture

UOK4

Agriculture

UOK5

Agriculture

UOK6

WWTP

UOK7

Agriculture

UOK6 offers the greatest insight of any of the sampling sites as to how WWTPs
introduce contamination of metformin and guanylurea in the aquatic environment.
Despite being one of the smallest watersheds investigated in the course of this work,
UOK6 registered the highest average concentration of both metformin and guanylurea in
surface water of 3.63 ± 3 µg/L metformin and 14.6 ± 4 µg/L guanylurea, much higher
than any other site. All other sites in the region are agriculturally influenced and exhibited
trends similar to the previous watersheds, where no sites but the WWTP-influenced
UOK6 contained above 0.25 µg/L guanylurea. The UOK1 site measured metformin only
once in the sampling period, and UOK2 did not contain metformin at all. The surface
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water data in this watershed emphasize the link between population size and widespread
contamination of metformin and guanylurea, as well as the link between WWTP effluent
and their presence in the environment.
For sediment sampling in the watershed, five of the six sites only contained guanylurea
once, while UOK2 did not register guanylurea above the LOD at all. Three sites (UOK1,
UOK2, and UOK5) only contained metformin once, at concentrations below 10 ng/g.
Interestingly, the agriculture site UOK3 which contained an average of 0.106 ± 0.1 µg/L
metformin in surface water had 237.683 ± 100 ng/g metformin in sediment. This may
indicate that the type of soil at this site can more easily adsorb metformin, or that the
bacterial species that degrades metformin to guanylurea is not present at this location. All
concentrations of both metformin and guanylurea in sediment at this watershed are
among the lowest of all sites examined in this study (Figure 17).
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Figure 17: Site map for the Upper Ottawa – Kipawa watershed. Ratios of metformin
to guanylurea at each site are provided as pie charts, the size of the pie chart
increases with total concentrations of both compounds.

2.4.6 Lower Ottawa – South Nation Results
The Lower Ottawa – South Nation watershed is sampled by South Nation Conservation
Authority (SNCA). The region lies just south of Ottawa and is 4441 km2, containing 16
different municipalities.115 The Lower Ottawa – South Nation watershed has extensive
sampling infrastructure, and contains the highest number of sampling sites of any
watershed with 13 total sites. The region is primarily agricultural, and that is reflected by
the 9 sampling sites with agriculture activity nearby (Table 7). There are, however, four
sampling sites taken from two lagoons and their outflows. A lagoon is a type of WWTP
which is treated over time using bacteria, UV and sometimes added chemicals. Samples
taken from this location are more analogous to samples taken directly from a WWTP
mid-treatment. This means that if degradation is occurring actively at these lagoon sites,
then samples taken mid-treatment should contain higher concentrations of metformin than
guanylurea. Each lagoon site was also paired with a sampling site at the lagoon outflows
where the treated effluent is then released. If concentrations of guanylurea are higher than
concentrations of metformin in the outflow, then this further reinforces that bacterial
degradation is occurring in the lagoon WWTP sites. If total concentrations are
diminished, this also indicates that the lagoon sites can completely degrade guanylurea as
well.
Table 7: Activity and Input at SNCA sampling sites
Sampling Site

Primary Activity

1

Agriculture

2

Agriculture

3

Agriculture

4

Agriculture

5

Agriculture

6

Agriculture
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7

Agriculture

8

Agriculture

9

Agriculture

10

Lagoon #1

11

Lagoon #1 Outflow

12

Lagoon #2

13

Lagoon #2 Outflow

The highest observed concentrations in the watershed were, as expected, the samples
from the lagoon sites. In surface water, lagoon sites 10 and 12 registered 2.409 ± 4 µg/L
and 1.602 ± 2 µg/L of metformin, and 0.932 ± 0.8 µg/L and 1.941 ± 1 µg/L guanylurea,
respectively. These lagoon sites contained a much higher ratio of metformin to
guanylurea with LOSN10 containing more metformin than guanylurea, a trend not seen in
any of the agriculture sites sampled in the watershed. Most notably from these results is
that the ratio does favour metformin, indicating that bacterial degradation is occurring in
the lagoons. Concentrations at the lagoon outflow sites 11 and 13 however, detected only
0.014 ± 0.007 µg/L and 0.141 ± 0.2 µg/L of metformin and 0.430 ± 0.010 µg/L and 0.406
± 0.2 µg/L of guanylurea, respectively, much lower than those concentrations seen in the
lagoons themselves. This is indicative of further bacterial degradation of guanylurea
occurring in the lagoon prior to release of the treated effluent back into the environment.
Other sites at the watershed even further reinforce those trends as seen in other
watersheds through the sampling, where agriculturally influenced sites were not
prominent sources of either compound. Not including the lagoon-influenced sites, only 1
site measured over 0.25 µg/L guanylurea at LOSN site 9, with a concentration of 0.301 ±
0.2 µg/L.
For the sediment sampling, trends proved similar to surface water. Guanylurea was only
detected once through the sampling period, at site 3. Metformin, however, was detected at
all the sampled sites, with the highest average concentration of metformin of 4047 ±
6111 ng/g occurring at the lagoon site LOSN12. This exceeds all other sampled sites by
10-fold, and the next highest concentration of metformin was 351.09 ng/g at LOSN13,
the outflow of the same site. Despite the extremely high concentration of metformin seen
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in sediment in site 12, concentrations of metformin in surface water for the site were
lower than the lagoon at site 10 and were comparable to several other non-lagoon sites.
This means that metformin is likely not persistent in lagoon outflow and the surrounding
surface water and can still resolubilize and degrade into guanylurea (Figure 18).
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Figure 18: Site map for the Lower Ottawa - South Nation watershed. Ratios of
metformin to guanylurea at each site are provided as pie charts, the size of the pie
chart increases with total concentrations of both compounds.

2.4.7 Upper Thames Results
The final watershed examined in this study is the Upper Thames region, which is sampled
by the Upper Thames River Conservation Authority (UTRCA). The Upper Thames
watershed contains the large urban centres of London, Woodstock, and Stratford, and the

50
rest is agriculture.116 With a total population of nearly 540 000, this region is the secondhighest population watershed investigated in this work. Three of the sampled sites are
near high-population areas, and the other two are more rural to give a complete picture of
contamination in the region [Table 8].

Table 8: Activity and Input at UTRCA sampling sites
Sampling Site

Primary Activity

1

Agriculture/Urban

2

WWTP

3

Urban

4

Agriculture

5

Agriculture

This watershed offered the interesting insight into higher populations and the general
effects those have on concentration of metformin and guanylurea. The highest
concentration of guanylurea measured at this watershed was at site 1, at 9.015 ± 7 µg/L,
which was the highest average concentration of guanylurea other than the WWTP
effluent pipe at UOK6. The influence at this site was urban and agriculture, not a WWTP,
which exhibits the effects that high populations can have on overall concentration of the
compounds. Total concentrations at sites 2 and 3 were also relatively high, at 3.31 and
4.65 µg/L, respectively. These sites had WWTP and urban activities nearby, while the
two agriculture-influenced sites at UT4 and UT5 measured average total concentrations
of 0.627 and 0.266 µg/L. Concentrations of guanylurea at all sites in this watershed were
above 0.2 µg/L and were higher than most other watersheds.
Sediment data for this watershed contained three of the highest concentrations of
metformin as detected through the sampling period that were not from lagoon or lagoon
outflow sites. Of the three sites with urban or WWTP influences, the lowest concentration
of metformin at these sites was 174.878 ± 60 ng/g. Of the total 30 samples that had
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guanylurea in quantifiable amounts, 13 of them were at this watershed. This may indicate
that higher population watersheds are constantly replenishing these compounds in the
environment through WWTP effluent or urban runoff as the compounds are known to be
very soluble and do not adsorb to sediment for long.6 This watershed further reinforces
the data seen previously at all other watersheds, but adds insight into the role population
and sampling sites have on average concentrations of the compounds. The sampling sites
containing greater than 1 µg/L total concentration in surface water and greater than 100
ng/g total concentration in sediment were all urban or WWTP influenced sites sampled
from close to highly populated cities (Figure 19).
UT4

10 µg/L or 100 ng/g
1 µg/L or 10 ng/g
0.1 µg/L or 1 ng/g

Sediment
- Metformin
UT1

- Guanylurea
Surface Water

UT3

UT2

- Metformin
- Guanylurea

UT5

Figure 19: Site map for the Upper Thames watershed. Ratios of metformin to
guanylurea at each site are provided as pie charts, the size of the pie chart increases
with total concentrations of both compounds.
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2.5 Conclusions
This work has clearly exhibited the prevalence of both metformin and guanylurea in
Ontario and Quebec waterways, and the utility of the method in detecting both
compounds. With LODs of 10 ng/L and 0.05 ng/g metformin and 100 ng/L and 0.6 ng/g
guanylurea in surface water and sediment respectively, levels of the compounds well
below toxic concentrations can be measured. Metformin and guanylurea were each seen
to be present in slightly over half of all water samples taken from 2018-2020, indicating
that they are common in the environment, and likely have been for some time.
Guanylurea was in higher concentration in most water samples than metformin, and the
opposite was true for sediment, indicating metformin is much more easily bound to
sediment where it can be more sufficiently retained. High concentrations at sampling sites
were not consistently high throughout the sampling period, further reinforcing previous
studies that indicate low sorption to sediment and high solubility in water. Higher
concentrations of guanylurea in most samples that contained both compounds as well as
the common occurrence of guanylurea in samples that did not contain metformin are
indicative of degradation of metformin in the environment to form its metabolite. The
sites that contained concentrations of guanylurea registering above the highlighted
potentially chronically toxic concentration of 0.25 µg/L were primarily WWTP, urban, or
lagoon influenced sites. This suggests that agriculture is not a prominent source of
contamination for either compound, and that insufficient degradation of metformin and
guanylurea in WWTPs is where most of its environmental contamination arises.
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Chapter 3
Investigating Effects of the Thermal Chemical Hydrolysis
Treatment on ESOCs in Biosolids
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3.1 Chapter 3 Objectives
The solid waste remaining after WWTP treatment of sewage can be used as fertilizer
provided it has been sufficiently treated. This treatment is only required to remove
bacteria and micropollutants, but it is unknown if it can remove or degrade other
compounds. As WWTP treatment cannot sufficiently degrade many complex
pharmaceuticals, these biosolids may contain environmental contaminants that are then
reintroduced into the environment. This study seeks to assess methods for extracting
ESOCs that may be present in the biosolids, and to determine if any of the compounds
change in concentration after treatment.

3.2 Introduction
Pharmaceuticals and personal care products (PPCPs) are an ever-increasing class of
chemicals used in everyday life by millions of people worldwide. This class includes a
wide array of common chemicals used in over-the-counter medications, cosmetics, and
veterinary drugs. Among them are some of the most widely used compounds in the
world, including caffeine, ibuprofen, and acetaminophen. While some of these
compounds are seen to decrease from influent to effluent in wastewater treatment plants
(WWTPs) such as caffeine,117 others are known to be insufficiently degraded. As such,
many PPCPs that enter a WWTP remain in the treated effluent and are released back into
the surface water.16,19,118,119 Human use and consumption of PPCPs in a region are
therefore linked to occurrence of those same PPCPs in the surrounding aquatic
environment.120 As new PPCPs are in constant development, their environmental impacts
are often unknown. Clinical trials on safety of newly developed drugs focus on their
efficacy in treating an illness and often overlook environmental effects upon their
excretion. This means that toxicity of environmental contaminants is an ever-present
issue that must be investigated for every new PPCP that is introduced to the aquatic
environment.
Municipal wastewater treatment plants receive millions of tons of solid waste per year.43
This solid waste, known as biosolid, remains behind with little productive use. The
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organic material that remains can be used as fertilizer in agriculture, provided it has been
processed to remove harmful micropollutants and bacteria. The Ontario Ministry of
Agriculture, Food and Rural Affairs (OMAFRA) regulates the land use of biosolids to
ensure they do not contain trace amounts of harmful elements like arsenic, lead, and
mercury.121 One method to process the solid and remove chemical contaminants is the
Thermal Hydrolysis process (THP), which uses basic pH conditions, heat and shearing of
the waste.122 The treatment of biosolids creates what is labelled by the Environmental
Protection Agency (EPA) as Class A fertilizer. Class A fertilizer are treated to be
determined pathogen-free and therefore safe to be distributed in public land without
restrictions.123 It is known that the THP method removes bacteria and does in fact create
Class A fertilizer, however it is unknown if ESOCs remain recalcitrant in these biosolids
and are therefore spread back into the environment when applied in agriculture.124 This is
a concern as many WWTPs are unable to fully degrade compounds like complex
pharmaceuticals, and many ESOCs are therefore present in the treated effluent
wastewater that is released into the environment every day.16,19,20,36 As the solid waste is
subjected to a similar process to wastewater, it is likely that many of the same
contaminants remain in the solid and should be investigated. It is of importance to ensure
that no environmental contaminants are present in high concentrations in the fertilizer
before it is applied such that biosolid application does not become a point source for
ESOCs in the environment. Biosolids before and after THP treatment will be analyzed to
allow for a direct observation of the effects of treatment on ESOCs present in organic
solids treated in WWTPs.
Two time points were examined for each WWTP to determine if there are temporal
effects that may change which compounds are detected in each sample, and whether they
increase or decrease in concentration. May and December samples from 2021 were
collected then extracted to have two data points in different seasons. This allowed for
comparison of the same compounds at different time points, and therefore the seasonal
distributions of compounds that may only be detectable in one point but not the other.
Mass spectrometry will be used to identify and quantify ESOCs in the biosolid samples
before and after treatment. The first method to be used is a nontargeted data independent
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analysis (DIA) method using the Orbitrap mass spectrometer. The purpose of this analysis
is to assess a nontargeted method for detecting ESOCs in biosolids. This DIA method will
be used to determine if it can effectively separate a wide variety of compounds from the
complex organic matrix.
A QqQ method has also been developed that will be used for targeted analysis of several
compounds of interest in environmental toxicology. Triple quadrupole mass spectrometry
is especially useful in examining complex organic solutions as the specificity of the
instrument for its target analytes allows it to overcome matrix effects which are so
prevalent. By individually analyzing target analytes and determining their fragmentation,
the compounds can be added to a target list with the parameters, such that subsequent
analyses will detect every compound on the list. This allows for a wide range of
environmentally relevant target compounds to be detected and analyzed, which can be
used to discern the severity of their contamination in the aquatic environment.

3.3 Materials and Methods
Solid waste samples were taken by a collaborator from three WWTPs at distinct locations
in May and December of 2021. Samples were treated with shearing in a benchtop reactor
at 75°C in 6M KOH for 90 minutes. Plastic containers were filled with roughly 500 mL
of sample and transported on ice before being extracted immediately then stored at 4°C.
Each of the three cake and fertilizer samples were extracted and analyzed in triplicate.

3.3.1 Nontargeted analysis method
To begin extraction of aqueous biosolid samples, 250 mg of the solid samples were
transferred into 15-mL conical PPE Falcon tubes, followed by 5 mL of 60:40
acetonitrile:pH 2 water. The pH of the mixture was adjusted to 2 with HCl. The mixture
was vortexed on a Vortex-Genie 2 model G-560 (Scientific Industries, Bohemia, NY) to
suspend the solid, then shaken for at 300 rpm on a VWR DS-500 orbital shaker (Avantor,
Radnor, PA, USA) for 30 minutes. The tubes were then centrifuged at 3000 rpm for 10
minutes in an Eppendorf 5810R benchtop centrifuge (Eppendorf, Mississauga, ON, CA),
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and the liquid was decanted into a clean 50-mL tube. The solid was then extracted again
with 5 mL of 50:50 acetonitrile:acetone, which was shaken and centrifuged in the same
conditions as the first extraction. The liquid extract was decanted into the same tube as
the first extract. HLB SPE cartridges were activated with 6 mL of methanol, followed by
6 mL acetonitrile, 6 mL methanol, then conditioned twice with 6 mL of pH 2 water each
time. The liquid extract was drawn under vacuum through the SPE cartridges at a rate of
roughly 1 drop per second. Once all liquid had been drawn through the cartridge, the
cartridges were washed with 3 mL of hexanes, then were allowed to air dry for 5 minutes.
The dried cartridges were then eluted into new 15-mL tubes with 3 additions of 1 mL
50:50 acetonitrile:methanol. The extracts were dried under a gentle stream of air, then
reconstituted in 1 mL methanol. The final extract was then filtered into 2-mL amber
HPLC vials (Agilent Technologies, Santa Clara, CA) through a 0.22 µm filter prior to
LC-MS analysis.
The extracts were analyzed using a Thermo Q-Exactive Orbitrap mass spectrometer
(Thermo Scientific, Waltham, MA, USA) coupled to an Agilent 1290 HPLC (Agilent
Technologies, Santa Clara, CA, USA). Chromatographic separation was performed using
an Agilent Zorbax EclipsePlus RRHD C18 column with an injection volume of 5 µL for
each sample at 35°C. The mobile phase consisted of 0.1% formic acid in water (A) and
0.1% formic acid in acetonitrile (B) using a flow rate at 0.3 mL min−1. The ion trap mass
spectrometer was used with a heated electro-spray ionization source (HESI), with
capillary temperature of 400°C; sheath gas, 17 arbitrary units; auxiliary gas, 8 units;
probe heater temperature, 450°C; S-Lens rf level, 45%; and capillary voltage, 3.9 kV.
Identification of contaminants using the DIA method was performed in MSDial software
version 4.90. To do so, .raw spectra files were converted into .mzml files using
Proteowizard msconvert version 3, then analyzed against the Swiss Federal Institute of
Aquatic Science and Technology (EAWAG, in original German Eidgenössische Anstalt
für

Wasserversorgung,

Abwasserreinigung

und

Gewässerschutz)

pesticide

and

pharmaceutical database. The software identifies correlation of the resulting spectra with
stored spectra for the target compounds and gives results based on their similarities.
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3.3.2 Targeted Triple Quadrupole method
Prior to weighing out the biosolids, roughly 5 g of each sample was spread onto
aluminum foil and left in a fume hood for 3 days to air dry at room temperature. Dried
biosolids were homogenized with a mortar and pestle then transferred for storage into a
50-mL conical PPE Falcon tube. Moisture content for each was measured to calculate
concentration of each ESOC in dry weight. This was done using a Sartorius MA37-1
Infrared Moisture Balance (Sartorius, Oakville, CA), which heats the sample and
determines the moisture percentage based on mass lost to evaporation. A phosphate
buffer was made with 5.99 g of KH2PO4, 5.40 g of K2HPO4 in 500 mL of NanoPure
water adjusted to pH 2 with 6M HCl. To begin extraction, 250 mg of each dried biosolid
sample was weighed and placed into a clean and dry 15-mL conical PPE Falcon tube. To
each tube, 5.0 mL of 60:40 acetonitrile:phosphate buffer (pH 2) was added. The mixture
was vortexed vigorously then shaken on a rotary shaker at 300 rpm for 30 minutes. The
solution was centrifuged for 10 minutes at 4000 rpm to separate the solid from the liquid
extract. The top liquid layer was decanted into a clean 15-mL tube. The solid was
extracted again with 5.0 mL of 50:50 acetonitrile:acetone, which was then vortexed,
shaken and centrifuged as described previously. The extract was decanted and combined
in the same 15-mL tube as the previous extract. Approximately 100 mg of
ethylenediaminetetraacetic acid (EDTA) iron (III) sodium salt (Sigma Aldrich, St Louis,
MO) was added to each extract, then the samples were shaken for 8 minutes prior to
spinning down by centrifugation at 4000 rpm. Finally, 2 mL of the extract was removed
and dried under a steady stream of nitrogen. The dried extracts were reconstituted in 1
mL of methanol, then diluted 1:1 in water.
All extracts were analyzed using a Thermo Vanquish Duo HPLC system coupled to a
Thermo Altis triple quadrupole mass spectrometer ((Thermo Fisher Scientific, Waltham,
MA, USA). The HPLC performed online preconcentration onto a Thermo hypersil GOLD
aQ (20x2.1mm, 12µm, Thermo Fisher Scientific, Waltham, MA, USA) precolumn and
backeluted onto an Agilent Zorbax C-18 column (50 x 2.1 mm; 1.8 µm, Agilent
Technologies, Santa Clara, CA) held at 35°C. A flow rate of 300 µL/min aqueous mobile
phase (A) of H2O + 0.1% Formic Acid (Optima™ LC/MS Grade, Fisher scientific,
Waltham, MA, USA) and organic mobile phase (B) of Acetonitrile + 0.1% Formic acid
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(Optima™ LC/MS Grade, Fisher Scientific, Waltham, MA, USA) was used throughout.
The gradient began with 2% B for 0.75 minutes before increasing to 15% over 1.05
minutes. B was increased to 24% over 5.6 minutes and to 98% over 15.1 minutes. B was
held at 98% for 2.4 minutes before returning to 2% in 0.1 minutes.
The heated electrospray ionization (HESI) source was set at the following conditions:
capillary voltage, 3.5kV; Sheath Gas, 35; Aux Gas, 10; Sweep gas, 1; Ion transfer tube
temperature, 325 °C; vaporizer temperature, 350 °C. A 0.7 Da and 1.2 Da resolution was
used for the first and third quadrupole, respectively. The collision gas was maintained at a
pressure of 1.5 mTorr. The multiple reaction monitoring (MRM) settings for 405 target
environmental contaminants are listed in Appendix 2. The bound residues were
quantified using Thermo TraceFinder software version 5.0 (Thermo Scientific, Waltham,
MA, USA). Final concentrations in the extracts were back calculated using volumes of
solvent and moisture percentage to enable comparison of dry weight concentration of
each contaminant.

3.4 Results and Discussion
3.4.1 Nontargeted Analysis of Biosolids
The nontargeted method resulted in a wide array of spectra. Each peak recorded in the
MS spectrum was fragmented to result in a paired MS2 spectrum. MSDial software then
analyzed every MS2 spectrum against the EAWAG database and returned a list of hits
and the level of confidence in its identification (Figure 20).
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A)

B)

Figure 20: Example of a) a low mass scan using DIA and b) resulting identification
of targets against the EAWAG pharmaceutical and pesticide database in MSDial
software.
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Despite the expectation of a large number of compounds to be present in the biosolid
sample, Orbitrap mass spectrometry with a nontargeted method proved difficult. Of the
several thousand chromatograms generated with distinct peaks, only 10 compounds were
identified by the software with low confidence. This indicates that matrix effects
experienced by the coeluting compounds are severe enough that the analytes are not
eluting where they are expected to or are supressed by other compounds. To conclusively
determine what compounds are present, a more selective targeted method should be used
with the QqQ.

3.4.2 Targeted Analysis of ESOCs in Biosolids
Quantification of the 405 target compounds in both cake and the treated fertilizer revealed
what occurred as a result of THP chemical treatment. (Figures 21-23). Data are expressed
as a comparison of concentration in the initial cake against the concentration in the
treated fertilizer on a logarithmic scale. This allows for a linear expression of each data
point and its concentration in both matrices. Compounds that appear along the y-axis are
present in only the treated fertilizer, meaning they were not extracted by the method in
the cake samples. This suggests some level of shielding or inhibition of extraction by the
complex organic matter in the cake. As the THP chemical treatment does not introduce
any new compounds and simply alkalizes and heats the cake, the compounds must be
present but are not available to extract. Compounds that are along the x-axis are present
only in the initial cake, and not in the treated fertilizer. This may in fact be indicative of
degradation of the compound, and the compounds along the x-axis may be removed by
THP treatment. Samples were analyzed in triplicate, and compounds were omitted from
the charts if they did not appear in at least two different samples between the 12 points at
each WWTP. This is done to ensure that the identification of a compound is not a false
positive, such that trends can accurately be assessed.
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Figure 21: Concentration of Target Compounds in Biosolid Cake from WWTP-A
before and after THP treatment
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Figure 22: Concentration of Target Compounds in Biosolid Cake from WWTP-B
before and after THP treatment
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Figure 23: Concentration of Target Compounds in Biosolid Cake from WWTP-C
before and after THP treatment
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Compounds above the trendline in each graph are seen to increase in concentration after
THP treatment. In general, many compounds did appear to increase, but most detected
compounds remained along the trendline and therefore did not change due to the
treatment. The significance of the concentration changes due to THP treatment was
examined using a Kruskal-Wallis test for non-parametric data, with false discovery rate
adjustment (FDR) and did not identify any of the changes as significant. This means that
the slight changes in concentration from cake to fertilizer can be attributed to random
variance between the samples. Therefore, THP treatment did not have any discernible
significant effect on ESOC concentration in biosolid samples. This does not account for
the presence of many compounds in the treated samples that were not present in the
original cake. We hypothesize that this is due to the complex organic matter in the cake
shielding ESOCs from extraction. Then, once exposed to the base, heat, and shearing that
are characteristic of THP, the matrix has been broken open to expose the target
compounds. This makes them extractible in fertilizer where they were not in cake. There
may be other factors that cause this increase in concentration, but it is not possible that
THP itself is introducing these chemicals as nothing beyond 6M KOH is added to the
untreated solids. Despite the limited effects of THP treatment, the QqQ method did prove
to be effective at detecting many different compounds of various classes (Appendix 2).
The general method enabled for extraction of ESOCs was able to extract 71 different
compounds in quantifiable levels. Some of these compounds detected are pesticides, like
the herbicide metolachlor, the fungicide imazalil, or the insecticide piperonyl butoxide,
among others. However, the most common compounds as detected in biosolid samples
were pharmaceuticals and other personal care products. This is expected as the primary
input to WWTPs is human waste from sewage systems. These pesticides may be derived
from agricultural runoff that find their way into surface water and then into water
treatment services, but the vast majority of these compounds should be from human
waste.
Despite the wide range of compounds detected in the samples, they were all in generally
low concentrations. Most of the compounds detected were in concentrations of 10 ng/g or
lower, while very few approached 100 ng/g. One compound, however, that was
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consistently present in all samples and was not affected by THP treatment was
telmisartan. Telmisartan was the highest concentration compound in all the time points
and samples tested, measuring over 100 ng/g in every sample. Telmisartan is an oral drug
used in treatment of hypertension which is left unchanged by the body. Roughly 98% of
telmisartan is excreted in its original form in feces, and is also stable from degradation in
basic conditions.125,126 Compounds with these characteristics are ones most expected to be
detected in biosolid samples.

3.5 Conclusions
Despite the expected effects of THP treatment, little change was observed from untreated
cake to class A biosolid fertilizer. None of the changes in concentration as a result of the
treatment were seen to be significant when tested in a Kruskal-Wallis significance test.
Though the changes were not significant, many of the concentrations were seen to
increase slightly after the treatment which may suggest that degradation of complex
polymers in the untreated cake in some way releases the bound contaminants. Of the
compounds detected in cake, many were insufficiently degraded in WWTPs and were
stable from degradation in basic conditions.
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Chapter 4
Solid Phase Extraction of ESOCs in Surface Water
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4.1 Chapter 4 Objectives
Contamination with ESOCs in Canadian waterways is an issue that must be constantly
monitored. These compounds vary greatly in their chemical structures and characteristics,
so a method that is able to extract and identify as many as possible would be valuable.
This study evaluates the use of solid phase extraction in isolating ESOCs from surface
water. Triple quadrupole mass spectrometry in conjunction with a large list of target
spectra created by our group enables these methods to detect many compounds with one
method of extraction.

4.2 Introduction
Due to the prevalence of many ESOCs in surface water around the world, it is important
to develop a method to isolate and identify as many compounds as possible. This would
simplify analysis for many compounds in surface water and increase our ability to process
a large number of samples rather than subjecting a single sample to multiple different
methods. Our group has created a target list for many common environmental
contaminants by injecting standards of the target at a known concentration and storing
spectral data, increasing our ability to detect each compound in an unknown mixture. This
target list can be employed to test for every compound on that list with a selective
targeted method and accurately identify if it is in the environmental sample. Compounds
can then be quantified to determine the severity of their contamination, and if they are
approaching toxic levels.
This study uses the extensive sampling from watersheds around Ontario and Quebec as
outlined in Chapter 2 to examine the extent of environmental contamination and how it
arises. This work seeks to further expand our understanding of contamination by
observing contamination of target compounds at various sites of different activity. By
categorizing the target analytes and at which sites they are most common, we can discern
which compounds are most relevant in environmental toxicology. The utility of this
dataset is in its ease of analysis and reliability of results from the targeted method, so it
can be applied to a multitude of investigations with collaborators.

69

4.3 Materials and Methods
Water samples were taken in monthly intervals from May to November from 2018 to
2020 using the same sampling method and geolocations as outlined in Section 2.3.1. Onelitre polyethylene terephthalate (PET) bottles (SystemsPlus, Baden, ON, CA) were filled
at the sampling site and shipped to AAFC at LRDC. Samples were stored at -20°C until
ready for analysis.
All glassware used in extraction was cleaned sequentially three times each with hot tap
water, MeOH, then acetone. The glassware was then dried in a 100 °C oven for at least
one hour, and up to 24 h until visible liquid had evaporated. This process removes all
trace contaminants that would be amplified by SPE and therefore detectable in the
resulting extracts. Water samples in PET bottles were placed into a sink filled with warm
water to thaw before being filtered under vacuum through a 1.6 µm inert glass microfiber
filter (Whatman, GF/C) to remove large particles like algae and silt. From each 1-L
bottle, two 200-mL aliquots were taken and decanted into separate clean and dry 500-mL
beakers. The aliquots were adjusted to pH 6.50 ± 0.02 and pH 2.00 ± 0.02 using
hydrochloric acid and sodium hydroxide.
Waters Oasis® HLB 200-mg solid phase extraction cartridges (Waters, Milford, MA)
were then used to extract the ESOCs from the surface water samples. Each 200-mL
aliquot taken from the original 1-L sample was extracted through one HLB cartridge, so
two solid phase extractions were performed for each original water sample. To begin
SPE, the cartridges were conditioned twice with 5 mL methanol to penetrate the bonded
alkyl groups on the cartridge. They were then equilibrated with water of pH 6.5 or pH 2,
to match the pH of the 200-mL aliquot being extracted. The 200-mL water samples were
then drawn at a rate of 1-2 drops/second through Teflon tubing under vacuum onto the
cartridges 12 aliquots at a time (Figure 24). The constant replenishment of water over the
course of the extraction caused the cartridges to remain wet throughout. This is important
as the pores in the sorbent must be wet to retain analytes. Once the entire water sample
had been drawn onto the cartridge, the tubing was removed, and the cartridges were
allowed to air dry for 5 minutes with the vacuum turned off to ensure no solvent remained
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in the cartridge. This leaves just the target analytes bound loosely to the monomer in the
SPE cartridge.

Figure 24: Typical setup for a set of SPE extractions. Two of these setups were
utilized in one round of extractions for a total of 12 extractions simultaneously.

Following extraction from the water samples onto the HLB cartridges, the bound analytes
were eluted into 15-mL conical Falcon PPE tubes (Figure 25). This was done with 1 mL
of methanol three times, then 1 mL of acetonitrile three times for a total of 6 mL. These
polar organic solvents were used one after the other to ensure that all bound analytes are
eluted from the cartridges. The extracts were then dried at 30 °C under a gentle stream of
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air in a gentle flow evaporator. The tubes were removed, and the remaining solids were
reconstituted in a solvent of 80:20 methanol:water. Prior to analysis, 100 µL of each
fraction was combined into a single sample to detect all analytes with a single LCMS/MS experiment. As different compounds are eluted in the pH 6.5 and pH 2 fractions,
they are combined to allow for a full analysis of the compounds present in the original
water sample.

Figure 25: Setup for elution of one set of 12 HLB cartridges into 15-mL conical
tubes.

4.4 Results and Discussion
The targeted analysis of surface water was very effective at detecting a wide array of
ESOCs in surface water. A total of 833 samples were examined through four years at 40
different sites, in six different watersheds. Of the common environmental contaminants
on the target list, 257 different compounds were detected at least once in surface water
samples taken from 2017-2020 in Ontario and Quebec waterways (Table A5). Most
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compounds were detected at several different time points at different sampling sites.
Influences and activities at each site are consistent with Chapter 2. The compounds that
were found most often were the insect repellant N,N-diethyl-meta-toluamide (DEET),
and caffeine. DEET was found in every single water sample, and caffeine was found in
all but three of the 833 total samples. These two compounds are the most indicative of
human presence due to their extensive use and occurrence in surface water. Beyond these
two compounds, 110 of the 257 different identified compounds were PPCPs, and 111
were pesticides. The compounds from outside of these classes include chemicals such as
the industrial surfactant perfluorooctanoic acid, and the artificial sweetener acesulfame.
Of the 257 target compounds, 100 of them appeared in more than 10% of samples. These
compounds are those that would be most relevant in ecotoxicology as their occurrences
through the years of sampling can be more easily analyzed for trends.
Many compounds were found in fewer than 100 of the samples, among these was the
selective serotonin reuptake inhibitor (SSRI) antidepressant sertraline. Despite high usage
of the drug, even a study on hospital effluent in the Netherlands only found a maximum
concentration of 19.9 ng/L.127 This indicates that degradation of sertraline is likely
occurring in WWTPs, then it is further diluted through the watershed to remain present in
low concentrations. This is supported in this data as sertraline was only detected more
than once in 8 of the 40 total sites, all of which were WWTP influenced. In fact, every
single sample take from the WWTP effluent site UOK6 and the WWTP influenced site
UT1 contained sertraline while only 2 of its 73 total occurrences were in agriculturally
influenced sites. Even the agriculturally influenced sites in the same watershed as these
sites did not record sertraline, further indicating its low persistence and likely
degradation.
The corrosion inhibitor 4-methyl-1H-benzotriazole was one compound found frequently
through the surface water data, appearing in 819 off the 833 total samples. The compound
is also used as aircraft de-icing fluid, and has been seen to leech into surface water
downstream from airports.128 This extensive occurrence of the compound indicates that it
may be persistent in the environment, as it was seen in every sampling site multiple times
through each year, including the agricultural sites. Other compounds seen in over 90% of
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samples were the herbicides atrazine and metolachlor, as well as the common NSAID
acetylsalicylic acid, appearing in 814, 806, and 787 samples, respectively. Each of these
drugs sees extensive use in Canada, and the herbicides have been investigated previously
for their common occurrences.129,130 Acetylsalicylic acid is a common over the counter
drug used in Canada to treat inflammation, and has been previously detected in water
systems in Canada,131 as well as India,132 Korea,133 and many others. The common
occurrence of these compounds in this data further reinforces the validity and exhibits the
efficacy of the method in detecting a wide range of compounds. The data set resulting
from this work is extremely large but can be separated by average concentration of the
target ESOC in each site [Table 9]. This table is one small portion of the dataset, showing
only the 32 most abundant compounds as they appear in one of the six watersheds. Total
occurrences through all samples are noted to demonstrate the prevalence of certain
compounds, and they are classified by category to show the widespread contamination
from a variety of classes.
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Table 9: The Most Abundant ESOCs in Sampled Sites and their Average Concentrations in the Ausable Bayfield Watershed
Site

Compound Name

Category

Deet
Caffeine
4-Methyl-1H-benzotriazole
Metolachlor
Atrazine
acetylsalicylic acid
Metalaxyl
Paraxanthine
Chlorantraniliprole
24D
Sebacic acid
Imazethapyr
Fenuron
Acesulfame
Tebuconazole
Mirtazapine
Pyraclostrobin
Ethiofencarb
Bentazon
Clothianidin
Trifloxystrobin
Propiconazole
Difenoconazole
Azoxystrobin
Methamidophos
Carbamazepine
Gabapentin
Venlafaxine
Carbendazim
Thiamethoxam
Cetirizine
Tebuthiuron

Insect repellant; human
Human
industrial; corrosion inhibitor
herbicide
Herbicide; triazine
Pharmaceutical; human
fungicide
Human; metabolite; caffeine
insecticide
Herbicide
Industrial; Natural
herbicide
Herbicide
Artificial Sweetener
fungicide
pharmaceutical; antidepressant
fungicide
insecticide; carbamate
Herbicide
insecticide; neonicotinoid
fungicide
fungicide
fungicide
fungicide
Insecticide
pharmaceutical; anticonvulsant
pharmaceutical
pharmaceutical; human; antidepressant
Fungicide
insecticide; neonicotinoid
pharmaceutical; human; antihistamine
Herbicide

Total # of Occurrences
833
830
819
814
806
787
719
715
694
648
643
636
601
596
594
559
551
530
528
508
499
458
435
424
419
398
359
317
314
301
298
294

A1
Average
Concentration
(ng/L)

A2
Average
Concentration
(ng/L)

A3
Average
Concentration
(ng/L)

A4
Average
Concentration
(ng/L)

230.40 ± 670
6.50 ± 9
33.65 ± 100
71.97 ± 138
49.55 ± 138
216.42 ± 432
10.91 ± 23
4.22 ± 4
16.02 ± 20
15.04 ± 24
114.40 ± 74
10.79 ± 21
2.11 ± 2
24.06 ± 13
5.45 ± 4
16774.04 ± 25376
11.53 ± 1
21.59 ± 16
361.46 ± 1298
22.06 ± 40
3.29 ± 1
4.34 ± 4
2.64 ± 1
2.18 ± 3
16.62 ± 20
1.95 ± 3
23.21 ± 6
2.03 ± 4
0.21 ± 0.3
13.09 ± 11
2.91 ± 4
1.17 ± 1

90.50 ± 189
22.71 ± 24
20.07 ± 12
525.35 ± 1174
70.16 ± 108
163.02 ± 325
215.80 ± 801
5.57 ± 4
23.31 ± 54
176.95 ± 304
78.10 ± 24
59.18 ± 99
3.24 ± 3
75.60 ± 128
9.04 ± 9
7903.58 ± 8276
38.03 ± 87
21.64 ± 16
122.11 ± 300
39.70 ± 29
3.95 ± 2
9.42 ± 14
649.31 ± 2482
8.26 ± 12
17.00 ± 31
6.19 ± 7
199.26 ± 400
2.25 ± 2
0.52 ± 0.3
311.64 ± 821
1.95 ± 3
1.83 ± 1

113.15 ± 262
32.83 ± 81
52.72 ± 166
314.36 ± 554
122.22 ± 293
154.87 ± 187
11.13 ± 16
13.45 ± 32
18.86 ± 32
37.93 ± 86
99.19 ± 52
27.65 ± 76
3.55 ± 8
31.28 ± 63
6.78 ± 8
9727.59 ± 8210
11.33 ± 2
113.36 ± 350
141.38 ± 534
14.75 ± 18
4.36 ± 3
7.44 ± 12
3.56 ± 3
6.52 ± 18
34.03 ± 36
3.65 ± 3
38.06 ± 36
5.37 ± 4
0.33 ± 0.3
21.76 ± 38
2.57 ± 2
0.61 ± 0.4

240.50 ± 466
26.93 ± 57
126.93 ± 370
627.41 ± 785
145.46 ± 181
121.00 ± 134
64.10 ± 94
6.24 ± 7
50.93 ± 41
42.86 ± 53
84.39 ± 37
186.77 ± 320
1.82 ± 2
38.58 ± 48
20.95 ± 52
4835.17 ± 4336
31.74 ± 62
23.67 ± 27
44.20 ± 78
16.48 ± 14
12.37 ± 34
4.95 ± 9
5.29 ± 4
7.59 ± 21
8.94 ± 8
2.67 ± 6
35.43 ± 58
1.60 ± 2
0.14 ± 0.2
25.49 ± 33
1.31 ± 1
0.69 ± 1
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The trends observed in the dataset are to be further analyzed while examining specific
classes and types of compounds. One collaboration with ECCC is ongoing to analyze
pesticide concentrations throughout these waterways, as well as temporal trends
associated with those compounds. Due to the large amount of data points over three
years, distinct trends can be tracked for each compound or type of compound detected by
the method. One further ongoing work with this dataset is on long-term temporal trends
of pharmaceuticals and related compounds as they change through the course of the 2020
COVID-19 pandemic. This work will focus primarily on pharmaceuticals, as use of
medication through the pandemic may change in response to health initiatives and
treatment strategies.

4.5 Conclusions
These data are valuable in environmental analyses as any of the detected compounds can
be further investigated if they are identified as targets of interest. For example, with the
discovery of guanylurea, metformin became increasingly of interest in environmental
toxicology studies in 2014, though it had seen frequent usage since the 1950s. As
bacterial degradation of ESOCs can create any number of metabolites or degradation
products with varying toxicological effects, any of the ESOCs detected by this method
could become a future target. These data are also a useful tool in collaborations as any
study into compounds that were detected in these watersheds can be further supported by
this dataset. QqQ proved to effectively detect over 250 compounds from surface water
samples, and expansion of the target list would allow for even further identification.
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Chapter 5
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5.1 Metformin and Guanylurea in Ontario and Quebec
Waterways
The pharmaceutical metformin was found to be quite common throughout the surface
water at the watersheds examined, while its degradation product guanylurea was even
more so. In sediment, metformin was found in much higher amounts, and in far more
samples than guanylurea. This allowed for another view into contamination of metformin
and where it may accumulate. As sorption to soil is weak for both compounds but slightly
higher for metformin, these results were expected. The variety in activity at each
sampling site emphasized the primary route in which metformin and guanylurea enter the
environment. As agriculturally influenced sites measured the lowest concentrations of
both compounds in all watersheds tested, it can be concluded that agriculture is not a
point source for either compound in the environment. WWTPs, lagoons, and urban
influences were all much more common sources of the compounds and sites with those
activities nearby should be closely monitored to limit accumulation and linked toxic
effects.

5.2 ESOC Contamination of Biosolid Fertilizers
The method utilized in these extractions and quantifications of ESOCs in biosolids may
remain an invaluable tool in quantifying environmental contaminants that may be applied
in agriculture. Though the samples tested in this work were low in hazardous compounds,
it may remain an ongoing issue as populations increase and environmental PPCP
concentrations increase correspondingly. The work done in this section demonstrated the
issues with nontargeted analysis of complex matrices such as biosolids, and the need for
selective instrumentation such as with a QqQ. The ability for the QqQ to overcome the
matrix effects seen in the DIA method reinforces the utility of the instrument.
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5.3 Mass Spectrometry methods for Environmental Analyses
Mass spectrometry and its versatility is displayed throughout Chapter 4. A wide variety of
methods exist to extract and analyze ESOCs and the utility of several of them were
exhibited. Each of these methods will be used in the future as the sampling program
mentioned throughout this work has continued through 2021 and 2022 and should
continue in future years. Alternatives to SPE are being examined to eliminate the slow
turnover between runs and should allow for rapid evaluation of environmental samples.
The dataset resulting from targeted analysis of SPE samples if being evaluated for several
purposes and may yet be used in more ongoing investigations of compounds detected in
the surface water.

5.4 General Conclusions
In general, this work utilizes a variety of methods to identify and quantify emerging
substances of concern from several different matrices and demonstrates their utility. All
data gathered during this research can be used to further our understanding of
environmental contamination, and where it occurs. Mass spectrometry remains the gold
standard in environmental analyses due to its plethora of uses and selectivity of targets.
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Appendices
Appendix 1: Metformin and Guanylurea in Ontario and Quebec Waterways
Table A1: Average Metformin and Guanylurea Concentrations in water samples taken
from 2018-2020 with standard deviation
Watershed

1) Ausable

Site

Metformin

Std. Dev.

Guanylurea

Concentration

Concentration

(µg/L)

(µg/L)

Std. Dev.

1

0.016

0.007

0.176

0.08

2

0.019

0.03

0.234

0.1

3

0.023

0.02

0.313

0.5

4

0.040

0.03

0.226

0.07

1

0.350

0.4

4.201

7

2

0.190

0.1

0.265

0.1

3

0.413

0.3

0.308

0.1

4

0.100

0.1

0.315

0.2

5

0.131

0.07

0.393

0.1

1

0.189

0.1

2.825

2

2

0.035

0.06

0.212

0.1

3

0.027

0.02

0.219

0.1

4

0.429

0.4

2.012

1

5

0.010

0.008

0.246

0.1

6

0.028

0.04

0.193

0.07

4) Upper

1

0.144

0.127

0.07

Ottawa-

2

LOQ

0.243

0.1

Kipawa*

3

0.106

0.1

0.243

0.06

4

0.058

0.04

0.067

0.005

5

0.008

0.004

0.069

0.01

6

3.630

3

14.568

4

7

0.051

0.02

0.083

0.03

Bayfield

2) Cedar

3) Upper
Grand

92
5) Lower

1

0.027

0.03

0.195

0.1

Ottawa-

2

0.035

0.04

0.208

0.09

South

3

0.110

0.2

0.219

0.1

Nation

4

0.046

0.03

0.180

0.1

5

0.020

0.03

0.188

0.08

6

LOQ

0.079

0.01

7

0.005

0.000

0.141

0.09

8

0.110

0.000

0.111

0.05

9

0.008

0.003

0.301

0.2

10

2.409

4

0.932

0.8

11

0.014

0.007

0.430

0.01

12

1.602

2

1.941

1

13

0.141

0.2

0.406

0.2

6) Upper

1

0.166

0.1

9.015

7

Thames

2

0.271

0.2

3.039

2

3

0.298

0.3

4.350

3

4

0.186

0.2

0.441

0.3

5

0.056

0.06

0.209

0.1

Table A2: Average concentrations of Metformin and Guanylurea in 2020 Sediment
Samples
Site

Average

Average

Std.

Metformin

Guanylurea

Dev.

Concentration

Concentration

(ng/g)

(ng/g)
<LOQ

1) Ausable

A1

3.1

Bayfield

A2

46.1

Std. Dev.

75.3

2.64

0.376

93
A3

8.68

10.4

<LOQ

A4

37.3

26.2

1.13

C2

21.2

34.0

<LOQ

C3

25.4

27.1

2.93672

C4

28.2

16.9

<LOQ

UG1

34.9

32.1

1.99

UG2

44.3

57.2

0.544

UG3

16.3

14.2

<LOQ

UG4

25.8

34.4

1.05

UG5

47.1

64.5

0.973

UG6

20.2

11.5

0.672

4) Upper Ottawa-

UOK1

1.96

1.155

Kipawa

UOK2

7.43

<LOQ

UOK3

238

104

0.703

UOK4

5.28

2.90

0.870

UOK5

4.26

UOK7

21.2

2) Cedar

3) Upper Grand

5) Lower OttawaSouth
Nation

0.173

0.704
1.31

1.25
<LOQ

LOSN3
17.5

11.7

4.04

0.267

<LOQ

LOSN10 222

270

<LOQ

LOSN12 4047

6111

<LOQ

LOSN9

<LOQ

LOSN13 351

6) Upper Thames

0.382

UT1

175

61.4

1.44

UT2

276

216

23.0

22.7

UT3

251

300

1.71

1.75

UT4

30.329

30

141

128

UT5

17.1

16

19.3

19.0
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Appendix 2: Target ESOCs for Biosolid Analyses
Table A3: All ESOCs detected in biosolid samples
10-hydroxyamitriptyline

Fluxapyroxad

6PPD

Imazalil

Abiraterone Acetate

Irbesartan

Alectinib

Ketoconazole

Ametryn

Labetalol

Amitryptaline

Lamotrigine

Amlodipine

Lidocaine

Aripiprazole

Losartan

Atorvastatin

Metolachlor

Azithromycin

Metoprolol

Carbamazepine

Miconazole

Carvedilol

Mirtazapine

Celecoxib

Montelukast

Cetirizine

Moxifloxacin

Chlorhexidine

Norfluoxetine

Citalopram

O-desmethylvenlafaxine

Clarithromycin

Ofloxacin

Clethodim

Paroxetine

Clindamycin

Piperonyl butoxide

Clotrimazole

Propranolol

Clozapine

Quetiapine

Cyclobenzaprine

Sertraline

Deet

Sitagliptin

DesHEE-quetiapine

Spirodiclofen

Desmethylcitalopram

Sulisobenzone

Dextromethorphan

Tamsulosin

Diclofenac

Telmisartan

Didemethyl-citalopram

Testosterone enanthate
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Diltiazem

Tolnaftate

Diphenhydramine

Tolvaptan

Duloxetine

Trazodone

Fenhexamid

Triclocarban

Fexofenadine

Venlafaxine

Fludioxonil

Vilazodone

Fluoxetine

Ziprasidone

Flutriafol

Table A4: MRM settings for biosolid target analytes
Compound

CAS

Category

RT (min)

Ion Type

10-hydroxyamitriptyline

1159-82-6

pharmaceutical

6.15

[M+H]+

24D

94-75-7

Herbicide

11.39

[M-H]-

3-hydroxycarbofuran

16655-82-6

pesticide

4.94

4-Methyl-1H-benzotriazole

29878-31-7

industrial

abacavir

136470-78-5

pharmaceutical

Abiraterone Acetate

154229-18-2

pharmaceutical

acesulfame

55589-62-3

acetamiprid

135410-20-7

acetominophen
acetylsalicyclic acid

Precursor
m/z

Quantifier m/z
(CE)

Qualifier m/z
(CE)

instrumental
LOD (ng/L)

294.2

216 (28)

231 (21)

50

219

161 (17)

125 (28)

50

[M+H]+

238.1

181 (10)

163 (15)

5

5.08

[M+H]+

134.1

77 (27)

79 (20)

10

3.13

[M+H]+

287.2

134 (42)

79 (21)

5

15.31

[M+H]+

392.3

332 (34)

316 (48)

Artificial

1.44

[M-H]-

82 (14)

78 (31)

50

insecticide

5.78

[M+H]+

223.1

126 (21)

90 (33)

5

103-90-2

Pharmaceutical

2.69

[M+H]+

152.1

110 (16)

93 (25)

100

50-78-2

Pharmaceutical

6.09

[M-C2H2O-H]-

137.1

93 (17)

65 (29)

5000

acibenzolar-s-methyl

135158-54-2

Fungicide

13.03

[M+H]+

211

136 (31)

140 (25)

500

advantame

245650-17-3

Artificial

9.03

[M+H]+

459.2

252 (20)

102 (28)

50

albuterol

18559-94-9

pharmaceutical

5.99

[M+H]+

240.2

166 (14)

-

50

aldicarb

116-06-3

insecticide

7.28

[M+NH4]+

208.1

116 (10)

89 (16)

100

ametryn

834-12-8

Herbicide

8.27

[M+H]+

228.1

186 (18)

96 (25)

5

aminocarb

2032-59-9

insecticide

2.63

[M+H]+

209.1

152 (14)

137 (24)

1

amitryptaline

50-48-6

pharmaceutical

10.73

[M+H]+

278.2

105 (25)

117 (24)

500

Amlodipine

88150-42-9

pharmaceutical

10.58

[M+H]+

409.2

238 (10)

294 (11)

100

amoxacillin

26787-78-0

antibiotic

2.59

[M+H]+

366.1

114 (21)

208 (13)

100

anhydroerythromycin A

23893-13-2

antibiotic

10.66

[M+H]+

716.5

558 (17)

158 (30)

1000

aspartame

22839-47-0

Artificial

3.89

[M+H]+

295.1

120 (25)

235 (14)

500

atenolol

29122-68-7

pharmaceutical

2.7

[M+H]+

267.2

145 (27)

190 (20)

5

Atorvastatin

134523-00-5

pharmaceutical

14.34

[M+H]+

559.3

440 (23)

250 (42)

50

atrazine

1912-24-9

Herbicide

10.71

[M+H]+

216.1

174 (17)

132 (23)

1

azithromycin

83905-01-5

antibiotic

5.75

[M+2H]2+

375.3

591 (16)

434 (22)

100

azoxystrobin

131860-33-8

fungicide

13.98

[M+H]+

404.1

372 (15)

329 (31)

5

benalaxyl

71626-11-4

fungicide

15.59

[M+H]+

326.2

148 (22)

266 (14)

10

bendiocarb

22781-23-3

insecticide

10.11

[M+H]+

224.1

167 (10)

109 (17)

100

162

5000

96

bentazon

25057-89-0

Herbicide

10.74

[M-H]-

239.1

132 (26)

197 (20)

100

benzoximate

29104-30-1

insecticide

16.99

[M+H]+

364.1

199 (10)

184 (34)

1000

bezafibrate

41859-67-0

pharmaceutical

12.61

[M+H]+

362.1

316 (14)

139 (27)

100

bifenazate

149877-41-8

insecticide

14.53

[M+H]+

301.2

198 (10)

170 (19)

1000

boscalid

188425-85-6

fungicide

14.09

[M+H]+

343

307 (20)

271 (33)

500

Bromoxynil

1689-84-5

herbicide

10.97

[M+H]+

275.9

81 (35)

79 (50)

500

bromuconazole

116255-48-2

fungicide

13.51

[M+H]+

376

70 (21)

159 (28)

500

bupirimate

41483-43-6

fungicide

12.49

[M+H]+

317.2

166 (25)

237 (20)

1

buprofezin

69327-76-0

insecticide

14.54

[M+H]+

306.2

201 (13)

116 (17)

100

Bupropion

34911-55-2

pharmaceutical

5.95

[M+H]+

240.1

184 (13)

131 (29)

5

Human

3.29

[M+H]+

195.1

138 (19)

110 (22)

50

pharmaceutical

8.79

[M+H]+

360.2

244 (11)

174 (21)

50

veterinary

3.76

[M+H]+

263.1

231 (14)

129 (31)

50

caffeine
capecitabine
Carbadox

1958-08-02
154361-50-9
6804-07-05

Carbamazepine

298-46-4

pharmaceutical

9.97

[M+H]+

237.1

194 (21)

179 (34)

10

carbamazepine-10-11-epoxide

36507-30-9

pharmaceutical

7.44

[M+H]+

253.1

180 (30)

210 (15)

50

carbaryl

63-25-2

insecticide

10.81

[M+H]+

202.1

145 (10)

127 (29)

500

carbendazim

10605-21-7

Fungicide

3.02

[M+H]+

192.1

160 (18)

132 (31)

5

carbenicillin

4697-36-3

antibiotic

9.67

[M+H]+

379.1

204 (20)

238 (19)

5000

carbetamide

16118-45-9

insecticide

7.87

[M+H]+

237.1

192 (10)

118 (13)

100

carbofuran

1563-66-2

insecticide

10.05

[M+H]+

222.1

123 (22)

91 (35)

10

carvedilol

72956-09-3

pharmaceutical

10.26

[M+H]+

407.2

224 (22)

222 (24)

5000

Cefotaxime

63527-52-6

pharmaceutical

3.83

[M+H]+

456.1

396 (10)

324 (14)

500

Ceftiofur

80370-57-6

antibiotic

7.82

[M+H]+

524

241 (18)

210 (22)

100

ceftriaxone

73384-59-5

antibiotic

3.48

[M+H]+

555.1

396 (13)

324 (17)

100

Celecoxib

169590-42-5

pharmaceutical

15.01

[M+H]+

382.1

362 (29)

300 (30)

500

cetirizine

83881-51-0

pharmaceutical

10.85

[M+H]+

389.2

201 (19)

165 (55)

50

chloramphenicol

56-75-7

antibiotic

6.84

[M-H]-

321

152 (17)

257 (12)

100

chlorantraniliprole

500008-45-7

insecticide

12.81

[M+H]+

482

284 (13)

451 (17)

100

chlorbromuron

13360-45-7

herbicide

13.13

[M+H]+

293

125 (35)

182 (17)

500

chloroxuron

1982-47-4

herbicide

13.56

[M+H]+

291.1

72 (21)

164 (17)

100

Cilastatin

82009-34-5

pharmaceutical

3.98

[M+H]+

359.2

202 (15)

97 (23)

50

ciprofloxacin

85721-33-1

antibiotic

3.82

[M+H]+

332.1

288 (18)

245 (23)

50

citalopram

59729-33-8

pharmaceutical

9.2

[M+H]+

325.2

109 (29)

262 (20)

5

Clarithromycin

81103-11-9

antibiotic

11.15

[M+H]+

748.5

158 (29)

590 (18)

500

Clindamycin

18323-44-9

antibiotic

6.5

[M+H]+

425.2

126 (30)

377 (19)

10

Clindamycin phosphate

24729-96-2

pharmaceutical

6.2

[M+H]+

505.2

126 (32)

457 (21)

50

clofentezine

74115-24-5

insecticide

16.42

[M+H]+

303

138 (15)

102 (34)

5000

clopidogrel

113665-84-2

pharmaceutical

12.99

[M+H]+

322.1

212 (16)

184 (22)

1

clopidol

2971-90-6

antibiotic

3.11

[M+H]+

192

101 (27)

87 (32)

10

clopyralid

1702-17-6

Herbicide

3.12

[M-H]-

190

146 (9)

-

clothianidin

210880-92-5

insecticide

4.72

250

169 (13)

132 (17)

50

Clotrimazole

23593-75-1

pharmaceutical

[M+H]+
[MC3H4N2+H]+

277.1

165 (24)

241 (26)

1000

Clozapine

5786-21-0

pharmaceutical

6.3

[M+H]+

327.1

270 (25)

192 (46)

100

colchicine

64-86-8

pharmaceutical

8.18

[M+H]+

400.2

358 (22)

310 (26)

100

11.28

10000

97

cotinine

486-56-6

Human

0.92

[M+H]+

177.1

80 (24)

98 (25)

50

cyazofamid

120116-88-3

fungicide

15.62

[M+H]+

325.1

108 (14)

261 (10)

500

Cyclobenzaprine
Cycluron

303-53-7

pharmaceutical

10.45

[M+H]+

276.2

215 (41)

216 (24)

100

2163-69-1

Herbicide

10.83

[M+H]+

199.2

89 (15)

72 (22)

50

cyproconazole

94361-06-5

fungicide

13.17

[M+H]+

292.1

125 (30)

89 (53)

100

cyprodinil

121552-61-2

fungicide

11.66

[M+H]+

226.1

93 (35)

118 (31)

100

cyproterone acetate

427-51-0

pharmaceutical

15.05

[M+H]+

417.2

357 (16)

279 (25)

5000

cyromazine

66215-27-8

Insecticide

1.27

[M+H]+

167.1

68 (33)

125 (18)

100

Decoquinate

18507-89-6

pharmaceutical

17.5

[M+H]+

418.3

372 (25)

204 (44)

50

deet

134-62-3

Insect

11.18

[M+H]+

192.1

119 (18)

91 (30)

1

desHEE-quetiapine

5747-48-8

pharmaceutical

6.57

[M+H]+

296.1

210 (30)

253 (21)

50

Desmetryn

1014-69-3

Herbicide

6.16

[M+H]+

214.1

172 (18)

82 (29)

500

Desmycosin

11032-98-7

antibiotic

9.44

[M+H]+

772.4

174 (30)

407 (25)

5000

dextromethorphan

125-71-3

pharmaceutical

8.05

[M+H]+

272.2

215 (24)

171 (43)

dicamba

1918-00-9

Herbicide

8.13

[M-H]-

219

175 (7)

-

dichlorprop

120-36-5

Herbicide

12.63

[M-H]-

233

161 (28)

125 (28)

500

Diclazuril

101831-37-2

antibiotic

14.7

[M-H]-

405

334 (19)

299 (28)

1000

diclobutrazol

66345-62-8

fungicide

14.23

[M+H]+

328.1

159 (39)

123 (55)

1000

Dicrotophos

141-66-2

insecticide

3.9

[M+H]+

238.1

127 (19)

72 (26)

diethofencarb

87130-20-9

fungicide

13.5

[M+H]+

268.2

226 (10)

180 (18)

500

difenoconazole

119446-68-3

fungicide

15.65

[M+H]+

406.1

251 (26)

337 (18)

500

Diltiazem

42399-41-7

pharmaceutical

dimefuron

34205-21-5

herbicide

dimethoate

60-51-5

dimethomorph

110488-70-5

Dimoxystrobin

5
5000

5

9.75

[M+H]+

415.2

178 (26)

150 (45)

50

12.65

[M+H]+

339.1

167 (22)

140 (40)

500

insecticide

5.35

[M+H]+

230

199 (10)

125 (22)

50

fungicide

13.06

[M+H]+

388.1

301 (21)

165 (32)

100

149961-52-4

fungicide

15.03

[M+H]+

327.2

205 (10)

116 (23)

10

diniconazole

76714-16-4

fungicide

14.9

[M+H]+

326.1

Dinitolmide

148-01-6

Coccidiostat

5.24

[M-H]-

dinotefuran

165252-70-0

insecticide

2.94

diphenhydramine

58-73-1

Pharmaceutical

Diuron

330-54-1

herbicide

epoxiconazole

135319-73-2

fungicide

Erythromycin A

114-07-8

antibiotic

Esomeprazole

119141-88-7

pharmaceutical

Etaconazol

60207-93-4

Ethiofencarb

29973-13-5

ethiprole

70 (25)

159 (30)

50

224

181 (11)

42 (14)

500

[M+H]+

203.1

129 (12)

113 (10)

50

4.56

[M+H]+

256.2

167 (18)

152 (42)

50

11.37

[M+H]+

233

72 (18)

46 (17)

100

13.99

[M+H]+

330.1

121 (21)

123 (18)

50

9.71

[M+H]+

734.5

158 (30)

576 (20)

1000

5.55

[M+H]+

346.1

198 (11)

136 (32)

5

fungicide

13.72

[M+H]+

328.1

159 (29)

205 (17)

100

insecticide

11.17

[M+H]+

226.1

107 (10)

169 (10)

500

181587-01-9

insecticide

13.43

[M-H]-

395

331 (10)

262 (29)

500

ethirimol

23947-60-6

Fungicide

4.43

[M+H]+

210.2

140 (23)

98 (27)

Etoxazole

153233-91-1

insecticide

18.66

[M+H]+

360.2

141 (31)

304 (18)

fenamidone

161326-34-7

fungicide

14.03

[M+H]+

312.1

236 (15)

92 (25)

50

Fenarimol

60168-88-9

fungicide

13.52

[M+H]+

331

268 (23)

189 (50)

100

fenbuconazole

114369-43-6

fungicide

14.61

[M+H]+

337.1

194 (17)

91 (32)

10000

Fenhexamid

126833-17-8

fungicide

14.04

[M+H]+

302.1

97 (25)

55 (35)

500

fenobucarb

3766-81-2

insecticide

13.04

[M+H]+

208.1

95 (15)

152 (10)

100

5
5000

98

fenoxycarb

72490-01-8

insecticide

14.9

[M+H]+

302.1

88 (19)

116 (11)

5000

fenpropimorph

67564-91-4

fungicide

11.65

[M+H]+

304.3

147 (29)

130 (25)

500

Fenuron

101-42-8

Herbicide

4.7

[M+H]+

165.1

72 (16)

46 (14)

5

fexofenadine

83799-24-0

pharmaceutical

10.9

[M+H]+

502.3

466 (27)

171 (38)

10

Finasteride

98319-26-7

pharmaceutical

12.7

[M+H]+

373.3

305 (32)

317 (24)

500

fluazinam

79622-59-6

Fungicide

17.97

[M-H]-

463

416 (20)

398 (16)

5000

Flubendiamide

272451-65-7

insecticide

15.76

[M+H]+

683

408 (10)

274 (29)

10000

fludioxonil

131341-86-1

Fungicide

13.52

[M-H]-

247

180 (29)

152 (39)

1000

flufenacet

142459-58-3

herbicide

15.02

[M+H]+

364.1

152 (19)

194 (10)

500

Flunixin

38677-85-9

pharmaceutical

11.77

[M+H]+

297.1

264 (35)

259 (29)

50

fluometuron

2164-17-2

herbicide

10.88

[M+H]+

233.1

72 (19)

160 (27)

100

fluoxastrobin

193740-76-0

fungicide

15.15

[M+H]+

459.1

427 (0)

383 (22)

500

Fluoxetine

54910-89-3

pharmaceutical

11.12

[M+H]+

310.1

44 (14)

148 (9)

500

flupyradifurone

951659-40-8

insecticide

6.8

[M+H]+

289.1

126 (20)

90 (40)

10

Fluquinconazole

136426-54-5

fungicide

14.17

[M+H]+

376

349 (20)

307 (28)

500

fluridone

59756-60-4

herbicide

13.17

[M+H]+

330.1

309 (36)

310 (29)

10

Flusilazole

85509-19-9

fungicide

14.43

[M+H]+

316.1

247 (18)

165 (28)

50

flutolanil

66332-96-5

fungicide

14.89

[M+H]+

324.1

262 (19)

242 (26)

10

flutriafol

76674-21-0

fungicide

11.25

[M+H]+

302.1

123 (28)

95 (48)

100

Fluvoxamine

54739-18-3

pharmaceutical

10.55

[M+H]+

319.2

71 (17)

258 (12)

1000

Forchlorfenuron

68157-60-8

plant

11.05

[M+H]+

248.1

129 (18)

93 (32)

Fuberidazole

3878-19-1

Fungicide

3.41

[M+H]+

185.1

157 (22)

65 (42)

Furosemide

54-31-9

pharmaceutical

9.98

[M-H]-

329

285 (16)

205 (16)

500

gliclazide

21187-98-4

pharmaceutical

12.9

[M+H]+

324.1

91 (33)

127 (19)

500

Glipizide

29094-61-9

pharmaceutical

11.8

[M+H]+

446.2

321 (13)

286 (25)

100

GS-441524

1191237-69-0

pharmaceutical

2.53

[M+H]+

292.1

147 (32)

202 (11)

1000

guanylurea

141-83-3

Pharmaceutical

0.5

[M+H]+

103.1

60 (12)

43 (25)

500

halofuginone

55837-20-2

pharmaceutical

6.51

[M+H]+

414

120 (23)

138 (19)

50

hexaconazole

79983-71-4

fungicide

14.5

[M+H]+

314.1

70 (21)

159 (31)

100

hexaflumuron

86479-06-3

insecticide

15.15

[M+H]+

461

429 (10)

141 (38)

1000

hexazinone

51235-04-2

herbicide

8.15

[M+H]+

253.2

171 (16)

71 (30)

hexythiazox

78587-05-0

insecticide

18.26

[M+H]+

353.1

228 (15)

168 (24)

10000

Hydrochlorothiazide

58-93-5

pharmaceutical

3.24

[M-H]-

296

269 (20)

205 (24)

100

hydroxybupropion

357399-43-0

pharmaceutical

4.56

[M+H]+

256.1

130 (46)

139 (27)

50

imazamox

114311-32-9

herbicide

5.26

[M+H]+

306.1

261 (20)

246 (25)

50

imazethapyr

81335-77-5

herbicide

7.13

[M+H]+

290.1

245 (22)

177 (28)

10

imidacloprid

138261-41-3

insecticide

5.12

[M+H]+

256.1

209 (16)

175 (18)

50

ipconazole

125225-28-7

fungicide

15.69

[M+H]+

334.2

70 (23)

125 (39)

1000

Iprovalicarb

140923-17-7

fungicide

13.71

[M+H]+

321.2

119 (20)

203 (10)

50

Irbesartan

138402-11-6

pharmaceutical

11.01

[M+H]+

429.3

195 (22)

180 (41)

50

isoprocarb

2631-40-5

Insecticide

11.69

[M+H]+

194.1

95 (15)

137 (10)

500

Isoproturon

34123-59-6

Herbicide

11.34

[M+H]+

207.1

72 (18)

165 (14)

10

labetalol

36894-69-6

pharmaceutical

6.75

[M+H]+

329.2

162 (26)

294 (19)

100

lamotrigine

84057-84-1

pharmaceutical

4.28

[M+H]+

256

211 (25)

166 (28)

100

50
5

10

99

lidocaine

137-58-6

pharmaceutical

3.79

[M+H]+

235.2

86 (18)

58 (32)

5

lincomycin

154-21-2

antibiotic

3.14

[M+H]+

407.2

126 (28)

359 (19)

5

linezolid

165800-03-3

antibiotic

5.76

[M+H]+

338.2

296 (17)

235 (21)

50

linuron

330-55-2

herbicide

13.24

[M+H]+

249

160 (18)

182 (15)

500

Lisinopril

76547-98-3

pharmaceutical

3.18

[M+H]+

406.2

84 (28)

246 (23)

500

Losartan

114798-26-4

pharmaceutical

11.24

[M+H]+

423.2

207 (22)

377 (15)

50

maduramicin

84878-61-5

antibiotic

23.98

[M+Na]+

939.5

877 (37)

895 (50)

1000

malathion

121-75-5

insecticide

14.77

[M+H]+

331

127 (12)

285 (10)

1000

Mandipropamid

374726-62-2

fungicide

14.28

[M+H]+

412.1

328 (15)

356 (10)

500

mecoprop

93-65-2

Herbicide

12.64

[M-H]-

213

141 (17)

-

500

mefenacet

73250-68-7

herbicide

13.94

[M+H]+

299.1

148 (15)

120 (25)

50

melengestrol acetate

2919-66-6

Feed

15.4

[M+H]+

397.2

337 (14)

279 (20)

1000

Meloxicam

71125-38-7

pharmaceutical

12.49

[M+H]+

352

115 (19)

141 (20)

50

mepanipyrim

110235-47-7

fungicide

14.18

[M+H]+

224.1

77 (38)

106 (26)

100

Mepronil

55814-41-0

fungicide

14.6

[M+H]+

270.1

119 (24)

228 (15)

50

meropenem

119478-56-7

antibiotic

3.02

[M+H]+

384.2

141 (16)

254 (16)

500

metalaxyl

57837-19-1

fungicide

11.49

[M+H]+

280.2

220 (14)

248 (10)

50

metconazole

125116-23-6

fungicide

14.72

[M+H]+

320.2

70 (24)

125 (39)

500

metformin

657-24-9

Pharmaceutical

0.5

[M+H]+

130.1

60 (22)

85 (16)

100

methabenzthiazuron

18691-97-9

Herbicide

10.31

[M+H]+

222.1

165 (17)

150 (33)

50

Methamidophos

10265-92-6

Insecticide

1.36

[M+H]+

142

94 (14)

125 (14)

50

methiocarb

2032-65-7

insecticide

13.18

[M+H]+

226.1

169 (10)

121 (19)

500

methomyl

16752-77-5

Insecticide

3.48

[M+H]+

163.1

106 (10)

88 (10)

50

Methoprotryne

841-06-5

herbicide

8.78

[M+H]+

272.2

240 (19)

198 (23)

10

methoxyfenozide

161050-58-4

insecticide

14.59

[M+H]+

369.2

149 (17)

313 (10)

50

Metobromuron

3060-89-7

herbicide

11.71

[M+H]+

259

148 (15)

170 (19)

100

Metolachlor

51218-45-2

herbicide

14.68

[M+H]+

284.1

252 (15)

176 (26)

10

metoprolol

51384-51-1

pharmaceutical

4.59

[M+H]+

268.2

116 (18)

159 (21)

5

metribuzin

21087-64-9

Herbicide

8.83

[M+H]+

215.1

187 (18)

84 (22)

50

Mexacarbate

315-18-4

insecticide

3.38

[M+H]+

223.1

151 (24)

166 (15)

mirtazapine

85650-52-8

pharmaceutical

4.04

[M+H]+

266.2

195 (28)

72 (20)

500

monensin

17090-79-8

antibiotic

22.57

[M+Na]+

693.4

461 (55)

479 (55)

1000

monocrotophos

6923-22-4

insecticide

3.51

[M+H]+

224.1

127 (16)

193 (10)

10

monolinuron

1746-81-2

Herbicide

11.15

[M+H]+

215.1

126 (18)

148 (15)

500

morpholino diethyl ether

6425-39-4

Industrial

0.6

[M+H]+

245.2

114 (31)

158 (18)

50

moxifloxacin

151096-09-2

antibiotic

5.79

[M+H]+

402.2

358 (19)

261 (26)

500

myclobutanil

88671-89-0

fungicide

13.77

[M+H]+

289.1

125 (33)

89 (55)

50

mycophenolate mofetil

128794-94-5

pharmaceutical

9.5

[M+H]+

434.2

114 (28)

285 (25)

100

Narasin

55134-13-9

antibiotic

23.37

[M+Na]+

787.5

431 (53)

531 (45)

10000

neotame

165450-17-9

Artificial

10.13

[M+H]+

379.2

172 (24)

319 (18)

5

nitenpyram

150824-47-8

insecticide

3.42

[M+H]+

271.1

225 (12)

99 (15)

50

nitrofurantoin

67-20-9

Pharmaceutical

4.09

[M-H]-

237

152 (12)

194 (9)

500

norfluoxetine

126924-38-7

pharmaceutical

10.84

[M+H]+

296.1

134 (7)

-

novobiocin

303-81-1

antibiotic

15.45

[M+H]+

613.2

189 (27)

218 (12)

5

1000
500

100

Nuarimol

63284-71-9

fungicide

12.42

[M+H]+

315.1

252 (22)

207 (47)

50

O-desmethylvenlafaxine

93413-62-8

pharmaceutical

3.99

[M+H]+

264.2

58 (20)

133 (27)

10

ofloxacin
olanzapine

82419-36-1

antibiotic

3.73

[M+H]+

362.2

318 (20)

261 (28)

10

132539-06-1

pharmaceutical

3.03

[M+H]+

313.1

256 (24)

198 (44)

100

omethoate

1113-02-6

insecticide

2.69

[M+H]+

214

183 (11)

125 (22)

10

oxadixyl

77732-09-3

fungicide

9.09

[M+H]+

279.1

219 (10)

132 (31)

500

oxolinic acid

14698-29-4

pharmaceutical

6.95

[M+H]+

262.1

216 (30)

160 (39)

100

oxytetracycline

79-57-2

antibiotic

3.71

[M+H]+

461.2

426 (21)

337 (30)

100

Paclobutrazol

76738-62-0

fungicide

12.9

[M+H]+

294.1

70 (21)

125 (38)

50

paliperidone

144598-75-4

pharmaceutical

5.76

[M+H]+

427.2

207 (29)

110 (41)

50

Pantoprazole

102625-70-7

pharmaceutical

7.19

[M+H]+

384.1

200 (15)

138 (31)

10

Paroxetine

61869-08-7

pharmaceutical

10.2

[M+H]+

330.2

192 (22)

151 (22)

1000

penconazole

66246-88-6

fungicide

14.49

[M+H]+

284.1

123 (49)

173 (30)

100

pencycuron

66063-05-6

fungicide

16.53

[M+H]+

329.1

125 (26)

218 (16)

50

Picoxystrobin

117428-22-5

fungicide

15.86

[M+H]+

368.1

145 (22)

205 (10)

10

piperacillin

61477-96-1

antibiotic

9.55

[M+H]+

518.2

143 (21)

160 (11)

100

pirimicarb

23103-98-2

insecticide

4.35

[M+H]+

239.2

182 (16)

72 (21)

Pravastatin

81093-37-0

pharmaceutical

10.34

[M-H]-

423.2

321 (14)

303 (13)

500

Prednisone

9.05

[M+H]+

359.2

267 (16)

265 (17)

500

prochloraz

67747-09-5

fungicide

13.01

[M+H]+

376

308 (12)

266 (17)

500

promecarb

2631-37-0

insecticide

13.47

[M+H]+

208.1

151 (10)

109 (16)

500

Prometon

1610-18-0

Herbicide

6.8

[M+H]+

226.2

142 (23)

184 (19)

10

Prometryn

7287-19-6

Herbicide

10.4

[M+H]+

242.1

158 (24)

200 (19)

10

propamocarb

24579-73-5

Fungicide

2.75

[M+H]+

189.2

102 (18)

144 (13)

10

Propazine

139-40-2

Herbicide

12.49

[M+H]+

230.1

146 (23)

188 (18)

50

propham

122-42-9

Herbicide

12.03

[M+H]+

180.1

138 (10)

120 (17)

5000

Propiconazole

60207-90-1

fungicide

14.91

[M+H]+

342.1

159 (30)

123 (54)

100

propoxur

114-26-1

insecticide

9.95

[M+H]+

210.1

111 (14)

168 (10)

100

propranolol

525-66-6

pharmaceutical

7.5

[M+H]+

260.2

116 (18)

183 (19)

50

prothioconazole

178928-70-6

fungicide

14.81

[M+H]+

344

326 (10)

154 (28)

5000

pymetrozine

123312-89-0

Insecticide

2.41

[M+H]+

218.1

105 (20)

78 (38)

pyraclostrobin

175013-18-0

fungicide

16.35

[M+H]+

388.1

194 (13)

163 (24)

5000

pyrimethanil

53112-28-0

Fungicide

8.48

[M+H]+

200.1

107 (24)

183 (24)

100

Quetiapine

111974-69-7

pharmaceutical

7.47

[M+H]+

384.2

253 (21)

221 (42)

50

Quinoxyfen

124495-18-7

fungicide

16.72

[M+H]+

308

197 (33)

162 (45)

5000

Ractopamine

97825-25-7

Feed

3.96

[M+H]+

302.2

164 (18)

121 (24)

50

Ramipril

87333-19-5

pharmaceutical

10.03

[M+H]+

417.2

234 (20)

117 (40)

50

Ranitidine

66357-35-5

pharmaceutical

2.76

[M+H]+

315.2

176 (19)

130 (26)

50

remdesivir

1809249-37-3

pharmaceutical

12.09

[M+H]+

603.2

200 (39)

402 (15)

5000

rimsulfuron

122931-48-0

herbicide

11.15

[M+H]+

432.1

182 (22)

325 (15)

100

risperidone

106266-06-2

pharmaceutical

5.9

[M+H]+

411.2

191 (29)

110 (49)

500

rosuvastatin

287714-41-4

pharmaceutical

12.02

[M+H]+

482.2

258 (33)

272 (34)

100

Artificial

2.75

[M-H]-

42 (26)

106 (23)

1000

antibiotic

22.41

431 (55)

531 (44)

500

Saccharin
salinomycin

1953-03-02

1981-07-02
53003-10-4

pharmaceutical

5

[M+Na]+

182
773.5

10

101

Salmeterol

89365-50-4

pharmaceutical

11.18

[M+H]+

416.3

380 (19)

232 (22)

10000

sebacic acid

111-20-6

Industrial

8.58

[M-H]-

201.1

139 (15)

137 (21)

500

sebuthylazine
sertraline

7286-69-3

Herbicide

12.52

[M+H]+

230.1

68 (36)

174 (18)

500

79617-96-2

pharmaceutical

11.15

[M+H]+

306.1

159 (30)

275 (13)

1000

simazine

122-34-9

Herbicide

8.1

[M+H]+

202.1

132 (19)

124 (18)

50

Simetryn

1014-70-6

Herbicide

6.09

[M+H]+

214.1

124 (20)

96 (24)

10

sitagliptin

486460-32-6

pharmaceutical

5.65

[M+H]+

408.1

235 (18)

193 (25)

50

sotalol

3930-20-9

pharmaceutical

2.68

[M+H]+

273.1

133 (27)

213 (18)

10

spiroxamine

118134-30-8

fungicide

11.8

298.3

144 (21)

100 (31)

500

stevioside

57817-89-7

Natural

10.15

[M+H]+
[M-C6H10O5H]-

641.3

479 (42)

317 (47)

10000

sucralose

56038-13-2

Artificial

3.88

[M+FA-H]-

441

395 (11)

359 (15)

5000

sulfadoxine

2447-57-6

antibiotic

5.59

[M+H]+

311.1

156 (20)

108 (25)

50

sulfamethazine

57-68-1

pharmaceutical

4

[M+H]+

279.1

186 (17)

124 (26)

50

sulfentrazone

122836-35-5

Herbicide

11.21

[M-H]-

385

307 (23)

240 (31)

500

sulisobenzone

4065-45-6

Sunscreen

5.92

[M-H]-

307

211 (40)

227 (24)

100

Tadalafil

171596-29-5

pharmaceutical

11.51

[M+H]+

390.1

268 (13)

204 (55)

500

Tamsulosin

106133-20-4

pharmaceutical

6.9

[M+H]+

409.2

228 (23)

271 (19)

100

Tazobactam

89786-04-9

antibiotic

2.64

[M+H]+

301.1

207 (16)

168 (15)

500

tebuconazole

107534-96-3

fungicide

14.26

[M+H]+

308.2

70 (23)

125 (37)

50

tebufenozide

112410-23-8

insecticide

15.42

[M+H]+

353.2

133 (19)

297 (10)

100

tebufenpyrad

119168-77-3

insecticide

17.2

[M+H]+

334.2

117 (36)

147 (26)

10000

Tebuthiuron

34014-18-1

Herbicide

telmisartan

144701-48-4

pharmaceutical

terbumeton

33693-04-8

Herbicide

Terbuthylazine

5915-41-3

Herbicide

Terbutryn

886-50-0

Herbicide

10.51

tetraconazole

67915-31-5

fungicide

14.26

tetracycline

60-54-8

antibiotic

4.03

thiabendazole

148-79-8

Fungicide

thiacloprid

111988-49-9

Thiamethoxam

153719-23-4

Thidiazuron

7.81

[M+H]+

229.1

172 (18)

116 (27)

10

10.96

[M+H]+

515.2

276 (39)

289 (50)

5000

7.1

[M+H]+

226.2

170 (18)

142 (25)

10

[M+H]+

230.1

174 (17)

132 (25)

5

[M+H]+

242.2

186 (19)

91 (28)

5

[M+H]+

372

159 (30)

70 (22)

100

[M+H]+

445.2

410 (18)

241 (35)

100

3.23

[M+H]+

202

175 (26)

131 (33)

10

insecticide

7.52

[M+H]+

253

126 (21)

90 (36)

50

insecticide

4.05

[M+H]+

292

211 (10)

132 (23)

50

51707-55-2

Herbicide

8.81

[M+H]+

221

102 (16)

128 (16)

500

thiobencarb

28249-77-6

herbicide

16.38

[M+H]+

258.1

125 (19)

89 (47)

500

thiophanate-methyl

23564-05-8

fungicide

9.98

[M+H]+

343.1

151 (20)

311 (10)

500

tolnaftate

2398-96-1

fungicide

17.7

[M+H]+

308.1

148 (15)

120 (29)

10000

Tolvaptan

150683-30-0

pharmaceutical

13.77

[M+H]+

449.2

252 (20)

119 (38)

5000

Trazodone

19794-93-5

pharmaceutical

6.8

[M+H]+

372.2

176 (26)

148 (34)

50

triadimefon

43121-43-3

fungicide

13.98

[M+H]+

294.1

197 (15)

225 (13)

100

triadimenol

55219-65-3

fungicide

12.9

[M+H]+

296

70 (10)

99 (15)

100

tricyclazole

41814-78-2

Fungicide

6.05

[M+H]+

190

163 (23)

136 (29)

50

trifloxystrobin

141517-21-7

fungicide

17.21

[M+H]+

409.1

186 (17)

145 (43)

1000

triflumizole

68694-11-1

fungicide

14.37

[M+H]+

346.1

278 (10)

43 (22)

500

Trimethoprim

738-70-5

antibiotic

3.49

[M+H]+

291.1

230 (24)

261 (25)

5

tylosin

1401-69-0

antibiotic

10.38

[M+H]+

916.5

174 (37)

772 (29)

500

102

vamidothion

2275-23-2

insecticide

4.66

[M+H]+

Vancomycin

1404-90-6

antibiotic

2.84

[M+2H]2+

venlafaxine

93413-69-5

pharmaceutical

6.35

Vilazodone

163521-12-8

pharmaceutical

8.06

Virginiamycin M1

21411-53-0

antibiotic

warfarin

81-81-2

zoxamide

156052-68-5

288

146 (12)

118 (23)

724.7

1305 (14)

1143 (17)

[M+H]+

278.2

58 (18)

121 (31)

10

[M+H]+

442.2

155 (38)

197 (31)

10000

11.78

[M+H]+

526.3

355 (17)

337 (21)

5000

pharmaceutical

13.18

[M+H]+

309.1

163 (15)

251 (19)

100

fungicide

16.12

[M+H]+

336

187 (22)

159 (39)

100

Appendix 3: Widespread ESOC Analysis in Surface Water
Table A5: Analytes detected in Surface water samples from 2018-2020
10-hydroxyamitriptyline

imazethapyr

24D

imidacloprid

3-hydroxycarbofuran

iminostilbene

4-Methyl-1H-benzotriazole

ipconazole

abacavir

Iprovalicarb

acephate

Irbesartan

acesulfame

isoprocarb

acetamiprid

labetalol

acetominophen

lamotrigine

acetylsalicyclic acid

lidocaine

acibenzolar-s-methyl

lincomycin

advantame

linuron

albuterol

Lisinopril

aldicarb

malathion

amitryptaline

Mandipropamid

Amlodipine

mecoprop

amoxacillin

mefenacet

aripiprazole

Meloxicam

aspartame

mepanipyrim

atenolol

Mepronil

Atorvastatin

metalaxyl

atrazine

methabenzthiazuron

5
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azoxystrobin

Methamidophos

bendiocarb

methiocarb

bentazon

methomyl

benzoximate

Methoprotryne

bezafibrate

methoxyfenozide

bifenazate

Metobromuron

boscalid

Metolachlor

Bromoxynil

metoprolol

bromuconazole

metribuzin

bupirimate

Mexacarbate

buprofezin

mirtazapine

Bupropion

monocrotophos

caffeine

morpholino diethyl ether

capecitabine

moxifloxacin

Carbadox

myclobutanil

Carbamazepine

mycophenolate mofetil

carbamazepine-10-11-epoxide

Narasin

carbaryl

neotame

carbendazim

nicarbazin

carbenicillin

nitenpyram

carbofuran

nitrofurantoin

Cefotaxime

norfluoxetine

Ceftiofur

novobiocin

ceftriaxone

Nuarimol

cetirizine

O-desmethylvenlafaxine

chloramphenicol

ofloxacin

chlorantraniliprole

olanzapine

chlorbromuron

omethoate

chloroxuron

oxadixyl

Cilastatin

oxolinic acid

ciprofloxacin

oxytetracycline
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citalopram

Paclobutrazol

Clindamycin

paliperidone

Clindamycin phosphate

Pantoprazole

clopidogrel

paraxanthine

clopidol

Paroxetine

clothianidin

pencycuron

Clozapine

penicillin V

colchicine

Perfluorooctanoic acid

cotinine

Picoxystrobin

cyazofamid

piperacillin

cyclamate

pirimicarb

Cyclobenzaprine

Pravastatin

cyproconazole

Prednisone

cyprodinil

prochloraz

cyromazine

Prometon

Decoquinate

Prometryn

deet

propamocarb

desHEE-quetiapine

Propazine

dextromethorphan

propham

dicamba

Propiconazole

dichlorprop

propoxur

Diclazuril

propranolol

diclobutrazol

pymetrozine

Dicrotophos

pyraclostrobin

diethofencarb

pyrimethanil

difenoconazole

Quetiapine

Diltiazem

Quinoxyfen

dimethoate

Ractopamine

dimethomorph

Ramipril

diniconazole

Ranitidine

Dinitolmide

remdesivir
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dinotefuran

risperidone

diphenhydramine

rosuvastatin

Diuron

Saccharin

epoxiconazole

sebacic acid

Esomeprazole

sebuthylazine

Etaconazol

sertraline

Ethiofencarb

simazine

Ethiofencarb sulfoxide

Simetryn

Etoxazole

sitagliptin

fenamidone

sotalol

Fenarimol

spiroxamine

fenbuconazole

sucralose

Fenhexamid

sulfadoxine

fenobucarb

sulfamethazine

fenpropimorph

sulfentrazone

Fenuron

sulisobenzone

fexofenadine

Tadalafil

Finasteride

Tamsulosin

fluazinam

Tazobactam

fludioxonil

tebuconazole

Flunixin

tebufenozide

fluometuron

Tebuthiuron

fluoxastrobin

terbumeton

Fluoxetine

Terbutryn

flupyradifurone

tetraconazole

Fluquinconazole

tetracycline

fluridone

thiabendazole

Flusilazole

thiacloprid

flutolanil

Thiamethoxam

flutriafol

Thidiazuron

Fluvoxamine

thiobencarb
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Forchlorfenuron

Tolvaptan

Furosemide

Trazodone

Gabapentin

triadimefon

gliclazide

triadimenol

Glipizide

tricyclazole

GS-441524

trifloxystrobin

guanylurea

triflumizole

Halofuginone

Trimethoprim

hexaconazole

Vancomycin

hexaflumuron

venlafaxine

hexazinone

Virginiamycin M1

Hydrochlorothiazide

warfarin

hydroxybupropion

Ziprasidone

imazamox
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